https://sofinnovapartners.com/team/julia-metzger2026-02-02T10:13:17Z https://sofinnovapartners.com/news/elicit-plant-validates-large-scale-performance-best-product-corn2026-09-04T08:38:06Z https://sofinnovapartners.com/team/hortense-fouilland2024-08-05T14:57:03Z https://sofinnovapartners.com/news/nitrase-therapeutics-announces-the-appointment-of-three-industry-veterans-to-its-board-of-directors2026-08-19T17:27:36Z https://sofinnovapartners.com/team/sylvie-chapoy2023-09-08T07:42:13Z https://sofinnovapartners.com/portfolio/tulyp-medical2025-11-04T06:59:10Z https://sofinnovapartners.com/portfolio/mozart-therapeutics2022-01-03T11:31:24Z https://sofinnovapartners.com/news/nuage-therapeutics-appoints-dr-stuart-hughes-as-ceo-and-vanessa-malier-as-chair2026-06-12T15:37:11Z https://sofinnovapartners.com/news/dna-script-management-team-appointment-bruno-poddevin2026-09-04T08:38:06Z https://sofinnovapartners.com/news/inventiva-board-directors-appointments2026-09-04T08:38:06Z https://sofinnovapartners.com/news/alia-therapeutics-appoints-adel-nada-as-independent-board-director2026-06-12T15:37:11Z https://sofinnovapartners.com/news/mediar-advances-first-class-fibrosis-portfolio-clinic-first-cohort2026-09-04T08:38:06Z https://sofinnovapartners.com/news/johnson-johnson-completes-acquisition-of-shockwave-medical2026-06-29T09:43:00Z https://sofinnovapartners.com/news/inventiva-appoints-andrew-obenshain-as-chief-executive-officer2026-06-12T15:37:11Z https://sofinnovapartners.com/portfolio/werewool2023-05-10T10:24:16Z https://sofinnovapartners.com/news/brightheart-welcomes-michael-butchko-as-an-independent-board-member2026-06-12T15:37:11Z https://sofinnovapartners.com/portfolio/bioclec2025-03-18T05:07:57Z https://sofinnovapartners.com/news/abivax-patient-reported-outcomes-data-phase-3-abtect-induction-trials2026-09-04T08:38:06Z https://sofinnovapartners.com/news/medtronic-announces-strategic-investment-in-pi-cardia-to-accelerate-innovation-for-complex-tavr2026-09-02T09:00:10Z https://sofinnovapartners.com/news/shockwave-medical-announces-agreement-to-acquire-neovasc2026-06-12T15:37:11Z https://sofinnovapartners.com/news/inspirna-appointment-karim-benhadji-m-d-chief-medical-officer2026-09-04T08:38:06Z https://sofinnovapartners.com/news/disco-pharmaceuticals-appoints-ajla-hrle-as-chief-business-officer2026-06-12T15:37:11Z https://sofinnovapartners.com/news/glycoera-ag-appoints-ganesh-v-kaundinya-as-president-and-chief-executive-officer2026-06-12T15:37:11Z https://sofinnovapartners.com/news/sofinnova-partners-portfolio-company-amolyt-pharma-to-be-acquired-by-astrazeneca2026-06-12T15:37:11Z https://sofinnovapartners.com/news/microphyt-appoints-two-new-directors2026-09-04T08:38:06Z https://sofinnovapartners.com/news/handbook-impact-accountability-vc-developed-coalition-impact-driven2026-09-04T08:38:06Z https://sofinnovapartners.com/news/comet-bio-announces-usd22m-round-of-equity-financing2026-06-12T15:37:11Z https://sofinnovapartners.com/news/purespring-therapeutics-receives-uk-cta-approval-phase-i-ii-trial2026-09-04T08:38:06Z https://sofinnovapartners.com/portfolio/mironid2022-01-03T11:31:24Z https://sofinnovapartners.com/news/arzeda-secures-usd38m-oversubscribed-funding-round2026-09-04T08:38:06Z https://sofinnovapartners.com/news/mediar-therapeutics-usd105-million-financing2026-09-04T08:38:06Z https://sofinnovapartners.com/portfolio/gfbiochemicals2025-02-20T15:01:30Z https://sofinnovapartners.com/news/betteromics-raises-usd20-million-series-a-financing-led-sofinnova2026-09-04T08:38:06Z https://sofinnovapartners.com/team/simon-turner2025-12-16T22:15:35Z https://sofinnovapartners.com/news/the-secrets-to-50-years-of-success-in-life-sciences-investment2026-06-12T15:37:14Z https://sofinnovapartners.com/news/brightheart-sets-new-standard-prenatal-chd-screening-study-published2026-09-04T08:38:06Z https://sofinnovapartners.com/news/tissium-appoints-maria-sainz-as-independent-board-member2026-06-12T15:37:14Z https://sofinnovapartners.com/news/abivax-announces-closing-of-usd747-5-million-public-offering2026-06-12T15:37:14Z https://sofinnovapartners.com/news/crescendo-biologics-zai-lab-has-initiated-global-phase-2-trial2026-09-04T08:38:06Z https://sofinnovapartners.com/news/production-operations-afyren-neoxy-plant-make-progress-first-lots2026-09-04T08:38:06Z https://sofinnovapartners.com/news/sensorion-completes-private-placement-eur35-million-subscribed2026-09-04T08:38:06Z https://sofinnovapartners.com/team/anis-belmili2026-02-02T10:05:19Z https://sofinnovapartners.com/news/afyren-begins-new-phase-industrial-strategy-first-plant-afyren-neoxy2026-09-04T08:38:06Z https://sofinnovapartners.com/news/corwave-completion-6-month-chronic-vivo-study2026-09-04T08:38:06Z https://sofinnovapartners.com/news/elevara-medicines-appoints-biotech-veteran-as-ceo2026-07-14T10:53:02Z https://sofinnovapartners.com/news/gradient-denervation-technologies-appointment-martin-grasse-chief2026-09-04T08:38:06Z https://sofinnovapartners.com/portfolio/muna-therapeutics2022-01-03T11:31:24Z https://sofinnovapartners.com/news/mainstay-medical-receipt-fda-approval-mri-labeling-reactiv8-r2026-09-04T08:38:06Z https://sofinnovapartners.com/news/ceo-spotlight-thierry-abribat-s-third-straight-win2026-06-12T15:37:14Z https://sofinnovapartners.com/features/2024-impact-report-delivering-impact2025-08-28T16:05:18Z https://sofinnovapartners.com/news/crescendo-biologics-secures-usd32m-expansion-cb307-phase-1b-trial-psma2026-09-04T08:38:06Z https://sofinnovapartners.com/news/abivax-announces-full-year-2025-financial-results-and-provides-business-updates2026-06-02T07:11:02Z https://sofinnovapartners.com/news/recor-medical-otsuka-medical-devices-positive-vote-u-food-drug2026-09-04T08:38:06Z https://sofinnovapartners.com/news/inotrem-positive-outcome-phase-ii-astonish-trial-septic-shock-patients2026-09-04T08:38:06Z https://sofinnovapartners.com/news/moon-surgical-completes-first-human-clinical-study-maestro-tm-surgical2026-09-04T08:38:06Z https://sofinnovapartners.com/team/david-evans2026-07-13T06:03:26Z https://sofinnovapartners.com/news/fda-approves-limflow-system-patients-chronic-limb-threatening-ischemia2026-09-04T08:38:06Z https://sofinnovapartners.com/team/matthieu-coutet2025-12-16T22:09:24Z https://sofinnovapartners.com/news/latent-labs-secures-usd50m-funding-realize-potential-ai-powered2026-09-04T08:38:06Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-appoints-lisa-m-olson-ceo-clinical-trial2026-09-04T08:38:06Z https://sofinnovapartners.com/news/inventiva-announces-a-eur20-1-million-issuance-of-royalty-certificates2026-06-12T15:37:14Z https://sofinnovapartners.com/news/biocortex-strategic-partnership-cd-biopharma-accelerate-global2026-09-04T08:38:06Z https://sofinnovapartners.com/news/bioptimus-hits-usd76m-funding-milestone-prepares-launch-foundation2026-09-04T08:38:06Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-mary-mccarthy-partner-firm-industrial2026-09-04T08:38:06Z https://sofinnovapartners.com/news/nitrase-therapeutics-expands-leadership-team-accomplished-drug2026-09-04T08:38:06Z https://sofinnovapartners.com/news/iomx-therapeutics-receives-regulatory-approval-clinical-trial2026-09-04T08:38:06Z https://sofinnovapartners.com/strategy/md-start2025-12-12T18:08:05Z https://sofinnovapartners.com/news/corwave-to-set-up-its-manufacturing-facility-and-expand-to-a-new-site-next-to-paris2026-06-12T15:37:17Z https://sofinnovapartners.com/news/moon-surgical-karl-storz-strategic-commercial-collaboration2026-09-04T08:38:06Z https://sofinnovapartners.com/news/inspirna-present-phase-1b-rgx-202-01-clinical-trial-data-2022-esmo2026-09-04T08:38:06Z https://sofinnovapartners.com/news/noema-pharma-extends-series-b-financing-round-closing-chf130-million2026-09-04T08:38:06Z https://sofinnovapartners.com/news/asahi-kasei-acquire-calliditas-therapeutics-ab-accelerate-growth2026-09-04T08:38:06Z https://sofinnovapartners.com/portfolio/elevara-medicines2025-10-22T05:23:57Z https://sofinnovapartners.com/news/nodthera-nlrp3-inhibitor-nt-0796-meets-primary-endpoint-inflammation2026-09-04T08:38:06Z https://sofinnovapartners.com/portfolio/dmc-biotechnologies2022-01-03T11:31:24Z https://sofinnovapartners.com/news/aavantgarde-bio-appoints-ram-palanki-as-chairman-of-its-board-of-directors2026-06-12T15:37:17Z https://sofinnovapartners.com/news/tulyp-medical-emerges-sofinnova-medtech-accelerator-fda-submission2026-09-04T08:38:06Z https://sofinnovapartners.com/news/sofinnova-partners-chair-sees-opportunity-on-the-horizon2026-06-12T15:37:17Z https://sofinnovapartners.com/news/sofinnova-s-newest-partners-discuss-their-career-paths2026-06-12T15:37:17Z https://sofinnovapartners.com/news/glycoera-ag-expands-board-of-directors-and-appoints-georges-gemayel-ph-d-as-chair2026-06-12T15:37:17Z https://sofinnovapartners.com/news/biotalys-secures-product-registration-in-california-for-evoca-strengthening-regulatory-pathway-for-its-lead-asset-evoca-ng2026-09-04T09:07:09Z https://sofinnovapartners.com/portfolio/Neurent Medical2026-02-11T06:49:34Z https://sofinnovapartners.com/team/sandy-diep2023-09-07T16:46:45Z https://sofinnovapartners.com/news/inventiva-screening-nativ3-phase-iii-clinical-trial-evaluating2026-09-04T08:38:06Z https://sofinnovapartners.com/news/noema-pharma-appoints-volker-knappertz-m-d-executive-vice-president2026-09-04T08:38:06Z https://sofinnovapartners.com/news/aavantgarde-appoints-ms-lauren-kaskiel-as-chief-business-officer2026-06-29T09:45:10Z https://sofinnovapartners.com/team/gabriela-sachet-fernandez2025-07-07T14:56:22Z https://sofinnovapartners.com/news/tissium-receives-fda-novo-authorization-coaptium2026-09-04T08:38:06Z https://sofinnovapartners.com/news/franche-comte-polyclinic-moon-surgical-maestro-system-simplicity-ease2026-09-04T08:38:06Z https://sofinnovapartners.com/news/neurent-medical-raises-eur62-5-million-oversubscribed-series-c2026-09-04T08:38:06Z https://sofinnovapartners.com/news/calliditas-primary-endpoint-met-phase-3-nefigard-trial-evaluating2026-09-04T08:38:06Z https://sofinnovapartners.com/news/signadori-bio-appoints-dr-selwyn-ho-mb-bs-chief-executive-officer2026-09-04T08:38:06Z https://sofinnovapartners.com/news/afyren-adds-new-hires-to-support-growth-in-france-and-expansion-abroad2026-06-12T15:37:17Z https://sofinnovapartners.com/news/proqr-positive-phase-1-target-engagement-data2026-09-04T08:38:06Z https://sofinnovapartners.com/news/micropep-technologies-appoints-georg-goeres-ceo-lead-next-phase2026-09-04T08:38:06Z https://sofinnovapartners.com/news/amolyt-pharma-announces-research-agreement-and-licensing-option-with-xoma2026-06-12T15:37:20Z https://sofinnovapartners.com/portfolio/alia-therapeutics2022-01-03T11:31:24Z https://sofinnovapartners.com/team/sara-saoud2024-10-17T12:00:58Z https://sofinnovapartners.com/news/alia-therapeutics-names-letizia-goretti-as-chief-executive-officer2026-06-12T15:37:20Z https://sofinnovapartners.com/news/tissium-u-commercial-launch-coaptium-r-connect-strategic-governance2026-09-04T08:38:06Z https://sofinnovapartners.com/news/mission-therapeutics-us-fda-approval-initiate-phase-ii-clinical-trial2026-09-04T08:38:06Z https://sofinnovapartners.com/news/johnson-and-johnson-to-acquire-shockwave-medical2026-06-12T15:37:20Z https://sofinnovapartners.com/team/anna-belousova2024-08-05T11:17:30Z https://sofinnovapartners.com/news/tom-burt-partner-sofinnova-partners-speaks-edison-group-open-house2026-09-04T08:38:06Z https://sofinnovapartners.com/news/arzeda-lead-major-nsf-funded-initiative-advancing-cell-free2026-09-04T08:38:09Z https://sofinnovapartners.com/news/reflexion-real-world-evidence-outcomes-registry-evaluate-treatment2026-09-04T08:38:09Z https://sofinnovapartners.com/news/sofinnova-partners-new-investment-nanophoria-developer-non-viral-drug2026-09-04T08:38:09Z https://sofinnovapartners.com/news/abivax-provides-operational-and-key-program-update2026-06-12T15:37:20Z https://sofinnovapartners.com/news/we-build-them-to-be-great-companies-anne-osdoit-tells-in-vivo2026-06-12T15:37:20Z https://sofinnovapartners.com/news/moon-surgical-announces-appointment-of-mark-toland-as-independent-board-member2026-06-12T15:37:20Z https://sofinnovapartners.com/news/nodthera-announces-appointment-of-greg-chow-as-chief-financial-and-business-officer2026-06-12T15:37:20Z https://sofinnovapartners.com/news/synthace-appoints-dr-donald-deieso-as-new-board-chair2026-06-12T15:37:20Z https://sofinnovapartners.com/news/inventiva-publication-nature-communications-results-native-phase-iib2026-09-04T08:38:09Z https://sofinnovapartners.com/news/nodthera-nlrp3-inhibitor-nt-0796-reverses-neuroinflammation-parkinson2026-09-04T08:38:09Z https://sofinnovapartners.com/news/bionyra-pharma-launches-usd165-million-oversubscribed-series-a2026-09-04T08:38:09Z https://sofinnovapartners.com/news/mironid-raises-46-million-in-series-b-financing-to-advance-clinical-development-of-its-treatment-for-rare-kidney-disease2026-08-05T09:42:46Z https://sofinnovapartners.com/news/mozart-therapeutics-raises-usd25-million-expanded-series-a-financing2026-09-04T08:38:09Z https://sofinnovapartners.com/news/hitgen-research-agreement-nitrase-therapeutics2026-09-04T08:38:09Z https://sofinnovapartners.com/news/aavantgarde-presents-positive-clinical-data-aavb-081-program-usher-1b2026-09-04T08:38:09Z https://sofinnovapartners.com/news/t-therapeutics-raises-gbp48-million-series-a2026-09-04T08:38:09Z https://sofinnovapartners.com/legal-terms2026-04-09T12:46:37Z https://sofinnovapartners.com/portfolio/artios-pharma2022-01-03T11:31:24Z https://sofinnovapartners.com/news/kiro-raises-eur13-8-million-digital-medicine2026-09-04T08:38:09Z https://sofinnovapartners.com/news/brits-call-for-tech-revolution-to-tackle-nhs-wait-times-deepc-joins-forces-with-bt2026-06-12T15:37:20Z https://sofinnovapartners.com/news/maestro-surgical-robotics-system-by-moon-surgical-now-ce-marked2026-06-12T15:37:22Z https://sofinnovapartners.com/strategy/biovelocita2026-07-21T15:54:30Z https://sofinnovapartners.com/news/asahi-kasei-completes-recommended-public-cash-offer-becomes-owner-932026-09-04T08:38:09Z https://sofinnovapartners.com/news/sustainable-performance-fibers-company-werewool-raises-usd3-7-million2026-09-04T08:38:09Z https://sofinnovapartners.com/news/abivax-positive-phase-3-results-abtect-8-week-induction-trials2026-09-04T08:38:09Z https://sofinnovapartners.com/news/moon-surgical-expands-to-gynecological-surgery2026-06-12T15:37:22Z https://sofinnovapartners.com/news/myricx-enters-into-antibody-license-agreement-with-biocytogen2026-06-12T15:37:22Z https://sofinnovapartners.com/features/sofinnova-partners-industrial-biotech-strategy2023-03-06T11:12:11Z https://sofinnovapartners.com/portfolio/hemab-therapeutics2025-10-27T10:34:31Z https://sofinnovapartners.com/news/micropep-raises-usd29m-series-b-funding-unveils-krisalix-proprietary2026-09-04T08:38:09Z https://sofinnovapartners.com/team/javier-nunez-vicandi2024-08-05T10:58:33Z https://sofinnovapartners.com/news/latent-labs-to-launch-latent-y-research-tier-with-a-live-event-in-london2026-07-14T19:42:32Z https://sofinnovapartners.com/privacy-notice2023-12-05T11:10:10Z https://sofinnovapartners.com/news/highlife-receives-ide-approval-initiate-us-pivotal-clinical-study2026-09-04T08:38:09Z https://sofinnovapartners.com/news/digital-medicine-pioneer-deepc-eur12-million-series-a-round-led2026-09-04T08:38:09Z https://sofinnovapartners.com/news/deepc-closes-series-a-extension-accelerate-global-deployment2026-09-04T08:38:09Z https://sofinnovapartners.com/news/aavantgarde-fda-orphan-drug-designation-uk-cta-approval-aavb-0392026-09-04T08:38:09Z https://sofinnovapartners.com/portfolio/prometheus-materials2022-06-06T13:45:12Z https://sofinnovapartners.com/news/limflow-raises-usd40-million-eur36-million-in-series-d-financing2026-06-12T15:37:22Z https://sofinnovapartners.com/news/sofinnova-partners-announces-myricx-bio-agrees-to-be-acquired-by-novartis2026-07-14T11:00:26Z https://sofinnovapartners.com/news/micropep-corteva-multi-year-research-collaboration2026-09-04T08:38:09Z https://sofinnovapartners.com/news/asceneuron-awarded-second-grant-michael-j-fox-foundation2026-09-04T08:38:09Z https://sofinnovapartners.com/news/chroma-medicine-leadership-appointment-biotech-business-leader-michael2026-09-04T08:38:09Z https://sofinnovapartners.com/news/comet-opens-world-s-first-high-purity-arabinoxylan-dietary-fiber-production-facility2026-05-25T10:36:33Z https://sofinnovapartners.com/news/techbio-startup-cure51-selects-10x-genomics-visium-hd-new-drug2026-09-04T08:38:09Z https://sofinnovapartners.com/news/aavantgarde-bio-fda-fast-track-designation-aavb-039-treatment2026-09-04T08:38:09Z https://sofinnovapartners.com/news/new-england-journal-medicine-publication-reports-positive-limflow-results2026-09-04T08:38:09Z https://sofinnovapartners.com/news/nanophoria-bioscience-secures-eur83-5-million-series-a2026-09-04T08:38:09Z https://sofinnovapartners.com/news/tenpoint-therapeutics-ltd-fda-approval-yuvezzitm-first-only2026-09-04T08:38:09Z https://sofinnovapartners.com/news/disco-pharmaceuticals-launches-surfaceome-company-eur-20-million-seed2026-09-04T08:38:09Z https://sofinnovapartners.com/news/global-debut-asc-setting-surgeon-point-surgery-center-moon-surgical2026-09-04T08:38:09Z https://sofinnovapartners.com/news/bon-vivant-french-leader-animal-free-dairy-proteins-closes-eur15m2026-09-04T08:38:09Z https://sofinnovapartners.com/news/cure51-launches-nhs-approved-study-cambridge-university-hospitals2026-09-04T08:38:09Z https://sofinnovapartners.com/news/sangamo-therapeutics-chroma-medicine-option-license-agreement-evaluate2026-09-04T08:38:09Z https://sofinnovapartners.com/news/lucia-faccio-comments-increased-interest-investors-rare-diseases-space2026-09-04T08:38:09Z https://sofinnovapartners.com/news/asceneuron-welcomes-barbara-angehrn-pavik-new-ceo-it-gears-up-next2026-09-04T08:38:09Z https://sofinnovapartners.com/news/galvanize-therapeutics-announces-first-commercial-procedures-using-the-new-aliya-ex-system2026-09-04T09:03:23Z https://sofinnovapartners.com/news/sofinnova-partners-launches-digital-medicine-strategy2026-09-04T08:38:09Z https://sofinnovapartners.com/news/cedric-moreau-discusses-apollo-deal-on-journal-des-biotechs2026-06-12T15:37:25Z https://sofinnovapartners.com/news/mediar-therapeutics-oversubscribed-usd76-million-series-b-financing2026-09-04T08:38:09Z https://sofinnovapartners.com/portfolio/hepta-medical2024-08-09T15:10:12Z https://sofinnovapartners.com/news/biotalys-announces-retirement-of-board-member-patrick-van-beneden2026-07-15T10:14:36Z https://sofinnovapartners.com/news/pi-cardia-successfully-performs-mitral-valve-splitting-with-shortcut-tm2026-06-12T15:37:25Z https://sofinnovapartners.com/news/tissium-advances-clinical-pipeline-in-hernia-repair-following-first-fda-authorization2026-06-02T13:38:43Z https://sofinnovapartners.com/news/purespring-therapeutics-fda-ind-clearance-phase-i-ii-clinical-trial2026-09-04T08:38:09Z https://sofinnovapartners.com/team/heloise-percheron2024-09-30T04:59:59Z https://sofinnovapartners.com/news/afyren-announces-signing-of-new-commercial-contract-with-us-nutraceutical-maker2026-06-12T15:37:25Z https://sofinnovapartners.com/portfolio/amolyt-pharma2023-01-06T18:12:55Z https://sofinnovapartners.com/news/gradient-denervation-technologies-enrolls-initial-patient-first-human2026-09-04T08:38:09Z https://sofinnovapartners.com/news/bioptimus-assembles-elite-scientific-advisory-board-build-next-gen-ai2026-09-04T08:38:09Z https://sofinnovapartners.com/news/lucia-faccio-italy-is-a-center-of-excellence-for-biotech2026-06-12T15:37:25Z https://sofinnovapartners.com/news/elevara-medicines-doses-first-patient-phase-2b-start-synergy-trial2026-09-04T08:38:09Z https://sofinnovapartners.com/news/world-first-corwave-s-undulating-membrane-heart-pump-implanted-in-first-patient2026-06-02T14:06:54Z https://sofinnovapartners.com/news/nchroma-bio-first-patient-dosed-phase-1-2-clinical-trial-epigenetic2026-09-04T08:38:09Z https://sofinnovapartners.com/news/gensight-biologics-obtains-funding-eur10-million-sofinnova-partners2026-09-04T08:38:09Z https://sofinnovapartners.com/news/amolyt-pharma-enters-into-definitive-agreement-to-be-acquired-by-astrazeneca2026-06-12T15:37:25Z https://sofinnovapartners.com/news/nodthera-positive-phase-1-study-readouts-nlrp3-inflammasome-inhibitors2026-09-04T08:38:09Z https://sofinnovapartners.com/news/sofinnova-partners-gustave-roussy-forge-strategic-alliance2026-09-04T08:38:09Z https://sofinnovapartners.com/team/josh-makower-md2025-07-07T14:53:41Z https://sofinnovapartners.com/news/prometheus-materials-strategic-partnership-green-stream-algae-scale2026-09-04T08:38:09Z https://sofinnovapartners.com/news/f2g-usd70-million-financing-advance-development-commercialization-new2026-09-04T08:38:09Z https://sofinnovapartners.com/news/hepta-medical-secures-5-7-million-series-a-led-bpi-france2026-09-02T09:56:28Z https://sofinnovapartners.com/news/may-health-ce-mark-treatment-women-pcos-related-infertility2026-09-04T08:38:09Z https://sofinnovapartners.com/news/dna-script-expands-access-demand-dna-synthesis-india-through2026-09-04T08:38:09Z https://sofinnovapartners.com/news/freya-biosciences-positive-phase-1-first-human-data-fb301-ivf-related2026-09-04T08:38:09Z https://sofinnovapartners.com/news/t-therapeutics-series-a-extension-usd91-million-advance-first-class2026-09-04T08:38:09Z https://sofinnovapartners.com/news/may-health-raises-11-7m-advance-novel-technology-treat-pcos-related2026-09-04T08:38:12Z https://sofinnovapartners.com/news/nodthera-is-first-demonstrate-reduction-neuroinflammation-clinic-brain2026-09-04T08:38:12Z https://sofinnovapartners.com/news/may-health-appoints-seasoned-medtech-executive-colby-holtshouse-as-president-and-ceo2026-06-12T15:37:25Z https://sofinnovapartners.com/news/elicit-plant-awarded-up-eur7-5-m-funding-european-commission2026-09-04T08:38:12Z https://sofinnovapartners.com/news/verley-secures-usd38-million-series-a-commercialize-high-performance2026-09-04T08:38:12Z https://sofinnovapartners.com/news/ferrer-acquires-worldwide-rights-asn90-o-glcnacase-inhibitor2026-09-04T08:38:12Z https://sofinnovapartners.com/news/nodthera-publication-presentation-cardiometabolic-clinical-data2026-09-04T08:38:12Z https://sofinnovapartners.com/news/papiernik-tells-bloomberg-that-biotech-is-essential-to-pharma-industry2026-06-12T15:37:28Z https://sofinnovapartners.com/news/chroma-medicine-nvelop-therapeutics-unite-form-nchroma-bio-securing2026-09-04T08:38:12Z https://sofinnovapartners.com/news/t-therapeutics-appoints-theodora-harold-chief-executive-officer2026-09-04T08:38:12Z https://sofinnovapartners.com/news/mediar-therapeutics-enters-into-a-collaboration-and-option-agreement-with-ono-pharma-to-develop-novel-treatments-for-fibro-inflammatory-diseases2026-08-17T06:44:15Z https://sofinnovapartners.com/news/bioptimus-proscia-collaborate-accelerate-ai-innovation-scientific2026-09-04T08:38:12Z https://sofinnovapartners.com/news/highlife-welcomes-stefan-pilz-as-new-chief-executive-officer2026-06-12T15:37:28Z https://sofinnovapartners.com/news/adc-innovator-myricx-bio-appoints-boston-based-mohit-rawat-ceo-expands2026-09-04T08:38:12Z https://sofinnovapartners.com/portfolio/verley-formerly-bon-vivant2025-03-28T16:14:11Z https://sofinnovapartners.com/team/andrew-m-weiss2025-09-04T13:14:44Z https://sofinnovapartners.com/news/sensorion-approval-initiate-lead-gene-therapy-candidate-sens-501-otof2026-09-04T08:38:12Z https://sofinnovapartners.com/news/gradient-denervation-technologies-enrolls-first-patient-early2026-09-04T08:38:12Z https://sofinnovapartners.com/news/biotalys-obtains-new-fungicide-resistance-class-for-its-first-biofungicide2026-06-12T15:37:28Z https://sofinnovapartners.com/news/glycoera-ag-announces-appointment-of-tanmoy-ganguly-ph-d-as-chief-scientific-officer2026-06-12T15:37:28Z https://sofinnovapartners.com/news/lupin-and-tenpoint-therapeutics-announce-strategic-partnership-to-commercialize-yuvezzi-in-the-european-union-the-united-kingdom-switzerland-norway-and-iceland2026-09-04T08:58:13Z https://sofinnovapartners.com/news/galvanize-therapeutics-raises-usd100-million-oversubscribed-series-c2026-09-04T08:38:12Z https://sofinnovapartners.com/news/noema-pharma-noe-105-gemlapodect-phase-2a-study-tourette-syndrome-met2026-09-04T08:38:12Z https://sofinnovapartners.com/portfolio/mablink-bioscience2024-07-10T10:08:59Z https://sofinnovapartners.com/news/elicit-plant-upcoming-us-biosolution-launch2026-09-04T08:38:12Z https://sofinnovapartners.com/team/aishwarya-parthasarathy2025-04-15T14:10:16Z https://sofinnovapartners.com/news/first-finished-products-made-recycled-styrene-generated-through2026-09-04T08:38:12Z https://sofinnovapartners.com/news/mainstay-medical-publication-clinical-results-comparing-older-patients2026-09-04T08:38:12Z https://sofinnovapartners.com/news/maxcyte-multi-platform-technology-license-partnership-genentech2026-09-04T08:38:12Z https://sofinnovapartners.com/team/ligia-vela-reid2024-09-27T18:43:01Z https://sofinnovapartners.com/team/mano-iyer2025-12-16T22:11:50Z https://sofinnovapartners.com/news/abivax-phase-3-abtect-maintenance-trial-results-evaluating-obefazimod2026-09-04T08:38:12Z https://sofinnovapartners.com/portfolio/brightheart2023-05-31T06:06:55Z https://sofinnovapartners.com/news/purespring-therapeutics-raises-gbp80-usd105-million-series-b-financing2026-09-04T08:38:12Z https://sofinnovapartners.com/news/muna-therapeutics-announces-ceo-transition-as-clinical-pipeline-advances2026-06-30T12:14:13Z https://sofinnovapartners.com/portfolio/borea-therapeutics2022-01-03T11:31:24Z https://sofinnovapartners.com/news/tulyp-medical-appoints-industry-veteran-steve-motes-ceo-lead-next2026-09-04T08:38:12Z https://sofinnovapartners.com/news/aavantgarde-appoints-dr-jayashree-sahni-as-chief-medical-officer2026-06-12T15:37:28Z https://sofinnovapartners.com/portfolio/biovelocita2025-07-04T17:49:53Z https://sofinnovapartners.com/news/corwave-announces-the-appointment-of-magalie-durre-che-as-chief-financial-officer2026-06-12T15:37:28Z https://sofinnovapartners.com/news/pi-cardia-receives-fda-breakthrough-device-designation-shortcut-tm2026-09-04T08:38:12Z https://sofinnovapartners.com/news/calliditas-therapeutics-license-agreement-viatris2026-09-04T08:38:12Z https://sofinnovapartners.com/news/women-on-both-sides-of-the-pitch-call-meet-at-virtual-round-table2026-06-12T15:37:31Z https://sofinnovapartners.com/news/pincell-development-key-transgenic-mouse-model-appointment2026-09-04T08:38:12Z https://sofinnovapartners.com/news/moon-surgical-launches-maestro-tm-platform-at-lee-health2026-06-02T14:07:31Z https://sofinnovapartners.com/news/baxfendy-approved-us-first-only-aldosterone-synthase-inhibitor2026-09-04T08:38:12Z https://sofinnovapartners.com/news/f2g-usd100-million-financing-advance-late-stage-development2026-09-04T08:38:12Z https://sofinnovapartners.com/news/aavantgarde-founder-cso-is-elected-president-european-society-gene2026-09-04T08:38:12Z https://sofinnovapartners.com/news/abivax-oversubscribed-eur49-2-million-crossover-financing2026-09-04T08:38:12Z https://sofinnovapartners.com/strategy/capital2026-07-21T15:17:20Z https://sofinnovapartners.com/news/mediar-therapeutics-first-cohorts-dosed-phase-1-clinical-trial-mtx-4392026-09-04T08:38:12Z https://sofinnovapartners.com/news/cincor-pharma-to-be-acquired-by-astrazeneca2026-06-12T15:37:31Z https://sofinnovapartners.com/news/elicit-plant-accelerates-international-expansion-response-climate2026-09-04T08:38:12Z https://sofinnovapartners.com/news/aavantgarde-appoints-dr-peter-k-kaiser-to-the-board-of-directors2026-06-12T15:37:31Z https://sofinnovapartners.com/team/estelle-rigaux2025-07-03T10:21:44Z https://sofinnovapartners.com/news/cincor-pharma-publication-new-england-journal-medicine-phase-2-brightn-baxdrostat2026-09-04T08:38:12Z https://sofinnovapartners.com/team/nicolas-tuvi2024-10-07T14:59:15Z https://sofinnovapartners.com/news/signature-of-a-partnership-agreement-with-kiro2026-06-12T15:37:31Z https://sofinnovapartners.com/news/asceneuron-expands-scientific-advisory-board-world-leading-experts2026-09-04T08:38:12Z https://sofinnovapartners.com/news/tenpoint-therapeutics-ltd-visus-therapeutics-inc-join-forces2026-09-04T08:38:12Z https://sofinnovapartners.com/news/tissium-clinical-results-coaptium-r-connect-system-atraumatic2026-09-04T08:38:12Z https://sofinnovapartners.com/news/deepc-university-hospital-basel-bring-one-world-most-widely-used-open2026-09-04T08:38:12Z https://sofinnovapartners.com/news/first-u-s-patient-successfully-treated-with-pi-cardia-s-shortcut-tm2026-06-12T15:37:31Z https://sofinnovapartners.com/news/mablink-bioscience-eur31-million-series-a-funding-round-led-sofinnova2026-09-04T08:38:12Z https://sofinnovapartners.com/news/afyren-is-ramping-up-its-efforts-to-create-a-new-path-for-organic-waste-recovery2026-06-12T15:37:31Z https://sofinnovapartners.com/news/corwave-achieves-major-regulatory-milestone-iso-13485-certification2026-09-04T08:38:12Z https://sofinnovapartners.com/news/sofinnova-partners-welcomes-mano-iyer-as-venture-partner2026-06-12T15:37:31Z https://sofinnovapartners.com/news/muna-therapeutics-awarded-usd4-9m-grant-michael-j-fox-foundation2026-09-04T08:38:12Z https://sofinnovapartners.com/news/sitryx-therapeutics-leadership-team-appointment-ravi-m-rao-chief2026-09-04T08:38:12Z https://sofinnovapartners.com/news/abivax-pricing-highly-oversubscribed-upsized-800m-702m-public-offering2026-09-04T08:38:12Z https://sofinnovapartners.com/news/pincell-announces-2-successful-in-vivo-studies-for-breakthrough-skin-disease-therapy2026-06-12T15:37:33Z https://sofinnovapartners.com/news/moon-surgical-expands-leadership-team-accelerate-commercial-growth2026-09-04T08:38:12Z https://sofinnovapartners.com/portfolio/verona-pharma-plc2023-06-09T04:32:48Z https://sofinnovapartners.com/news/pi-cardia-successfully-completes-enrollment-in-pivotal-study-for-shortcut-tm2026-06-12T15:37:33Z https://sofinnovapartners.com/news/video-sofinnova-partners-2024-annual-general-meeting2026-06-12T15:37:33Z https://sofinnovapartners.com/news/astrazeneca-closes-acquisition-of-amolyt-pharma2026-06-12T15:37:33Z https://sofinnovapartners.com/news/safeheal-closes-eur40-million-financing-co-led-sofinnova-partners2026-09-04T08:38:12Z https://sofinnovapartners.com/news/inventiva-announces-a-new-director-of-the-board-of-directors2026-06-12T15:37:33Z https://sofinnovapartners.com/team/elliott-puttock2024-09-27T19:12:01Z https://sofinnovapartners.com/team/enzo-petrelluzzi2024-08-05T15:25:28Z https://sofinnovapartners.com/news/sofinnova-publishes-2023-impact-report2026-06-12T15:37:33Z https://sofinnovapartners.com/news/brightheart-appoints-michael-butchko-as-chairman-of-the-board2026-06-12T15:37:33Z https://sofinnovapartners.com/team/monique-saulnier2025-12-16T22:18:25Z https://sofinnovapartners.com/team/paola-pozzi2025-12-16T22:15:02Z https://sofinnovapartners.com/team/kinam-hong2025-12-16T22:11:31Z https://sofinnovapartners.com/team/josko-bobanovic2026-02-02T10:07:33Z https://sofinnovapartners.com/team/michael-krel2025-12-16T22:12:49Z https://sofinnovapartners.com/team/ankeet-jethwa2026-02-02T10:30:31Z https://sofinnovapartners.com/team/tizian-rossetti2024-08-05T11:08:11Z https://sofinnovapartners.com/team/marion-gasperment2026-02-02T10:34:39Z https://sofinnovapartners.com/team/anta-ada-gkelou2025-12-16T22:10:32Z https://sofinnovapartners.com/team/bommy-lee2024-08-05T15:20:15Z https://sofinnovapartners.com/team/marc-lahoudie2024-08-05T15:18:34Z https://sofinnovapartners.com/team/nathalie-loreaux2024-08-05T15:21:03Z https://sofinnovapartners.com/news/industry-veteran-abbas-hussain-appointed-as-chair-of-asceneuron2026-06-12T15:37:33Z https://sofinnovapartners.com/news/latent-labs-latent-x2-ai-generated-antibodies-drug-like-developability2026-09-04T08:38:12Z https://sofinnovapartners.com/news/inventiva-appoints-chris-benecchi-as-chief-operating-officer2026-09-04T09:18:40Z https://sofinnovapartners.com/news/sitryx-nominates-sit-047-novel-oral-mthfd2-inhibitor-clinical2026-09-04T08:38:12Z https://sofinnovapartners.com/news/aavantgarde-bio-appoints-dr-natalia-misciattelli-as-chief-executive-officer2026-06-12T15:37:33Z https://sofinnovapartners.com/news/l-ecole-ai-creator-machine-teaching-technology-raises-3-million-usd2026-09-04T08:38:12Z https://sofinnovapartners.com/news/sofinnova-md-start-iii-refining-the-model2026-06-29T09:45:10Z https://sofinnovapartners.com/news/catamaran-bio-present-preclinical-data-asgct-annual-meeting-support2026-09-04T08:38:12Z https://sofinnovapartners.com/news/moon-surgical-receives-second-fda-clearance-covering-commercial2026-09-04T08:38:12Z https://sofinnovapartners.com/news/ingenix-raises-eur13m-sofinnova-partners-led-syndicate-scale-modality2026-09-04T08:38:12Z https://sofinnovapartners.com/news/aavantgarde-appoints-megan-zoschg-canniere-as-chief-regulatory-quality-officer2026-09-04T09:28:08Z https://sofinnovapartners.com/news/invivo-partners-joins-sofinnova-partners-in-signadori-bio2026-06-12T15:37:33Z https://sofinnovapartners.com/strategy/crossover2026-07-21T15:26:05Z https://sofinnovapartners.com/news/tissium-secures-eur60-million-support-commercial-clinical-activities2026-09-04T08:38:12Z https://sofinnovapartners.com/news/biotalys-intention-strategically-refocus-activities-prioritize-lead2026-09-04T08:38:12Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-david-evans-as-partner2026-07-13T06:11:31Z https://sofinnovapartners.com/news/genespire-gene202-granted-orphan-drug-designation-fda-ec2026-09-04T08:38:16Z https://sofinnovapartners.com/news/corwave-second-closing-series-c-funding-eur61m2026-09-04T08:38:16Z https://sofinnovapartners.com/news/reflexion-raises-usd80-million-to-broaden-cancer-treatment-options2026-06-12T15:37:33Z https://sofinnovapartners.com/news/partnership-french-cancer-research-network-ffcd-expands-bioptimus2026-09-04T08:38:16Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-boston-children-hospital-university-milan2026-09-04T08:38:16Z https://sofinnovapartners.com/portfolio/t-therapeutics2023-11-15T10:57:26Z https://sofinnovapartners.com/news/safeheal-r-closes-oversubscribed-eur35-million-series-c-equity-financing2026-06-02T14:16:16Z https://sofinnovapartners.com/portfolio/qorium2024-01-10T09:50:36Z https://sofinnovapartners.com/news/noema-pharma-phase-2a-study-results-cendifensine-women-vasomotor2026-09-04T08:38:16Z https://sofinnovapartners.com/news/cincor-pharma-to-be-added-to-russell-2000-r-and-russell-3000-r-indexes2026-06-12T15:37:33Z https://sofinnovapartners.com/news/hemab-therapeutics-announces-pricing-of-upsized-initial-public-offering2026-06-29T09:45:10Z https://sofinnovapartners.com/news/abivax-reports-positive-abtect-maintenance-part-2-results-obefazimod2026-09-04T08:38:16Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-publication-journal-clinical-investigation2026-09-04T08:38:16Z https://sofinnovapartners.com/news/may-health-data-feasibility-studies-novel-ovarian-rebalancing-tm2026-09-04T08:38:16Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-appoints-aled-williams-as-chief-executive-officer2026-06-12T15:37:36Z https://sofinnovapartners.com/portfolio/disco-pharmaceuticals2024-08-06T11:09:29Z https://sofinnovapartners.com/news/rasmus-holm-jorgensen-appointed-cfo-at-aavantgarde2026-06-12T15:37:36Z https://sofinnovapartners.com/news/abivax-secures-up-to-eur-150m-from-two-structured-debt-financing-transactions2026-06-12T15:37:36Z https://sofinnovapartners.com/news/tenpoint-therapeutics-launches-usd70-million-series-a-financing-reverse2026-09-04T08:38:16Z https://sofinnovapartners.com/news/haya-therapeutics-first-cohort-dosed-phase-1-clinical-trial-htx-0012026-09-04T08:38:16Z https://sofinnovapartners.com/news/statement-board-directors-calliditas-therapeutics-ab-publ-relation2026-09-04T08:38:16Z https://sofinnovapartners.com/news/deepc-ai-centre-value-based-healthcare-enter-partnership-accelerate2026-09-04T08:38:16Z https://sofinnovapartners.com/news/inspirna-interim-data-phase-1b-2-study-abequolixron-rgx-104-relapsed2026-09-04T08:38:16Z https://sofinnovapartners.com/news/antoine-papiernik-discusses-theranos-in-lively-france-culture-podcast2026-06-12T15:37:36Z https://sofinnovapartners.com/news/pi-cardia-hires-gary-gratson-to-lead-global-commercialization2026-06-12T15:37:36Z https://sofinnovapartners.com/news/nanophoria-awarded-second-place-prize-innlifes-i-protagonisti-dell2026-09-04T08:38:16Z https://sofinnovapartners.com/portfolio/betteromics2025-03-11T11:20:15Z https://sofinnovapartners.com/news/5-sofinnova-partners-portfolio-companies-selected-to-french-tech-1202026-06-12T15:37:36Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-initiates-phase-1-clinical-trial-with-lead-candidate-ent0012026-06-12T15:37:36Z https://sofinnovapartners.com/news/haya-therapeutics-raises-usd65-million-series-a-funding-deliver2026-09-04T08:38:16Z https://sofinnovapartners.com/news/corwave-grand-opening-manufacturing-facility-banks-seine-next-paris2026-09-04T08:38:16Z https://sofinnovapartners.com/news/bioptimus-unveils-m-optimus-a-world-model-for-biology2026-06-12T15:37:36Z https://sofinnovapartners.com/news/the-knowledge-project2026-06-12T15:37:36Z https://sofinnovapartners.com/news/maxcyte-signs-strategic-platform-license-catamaran-bio-support-car-nk2026-09-04T08:38:16Z https://sofinnovapartners.com/news/inotrem-essential-phase-ii-study-treatment-critically-ill-covid-192026-09-04T08:38:16Z https://sofinnovapartners.com/news/moon-surgical-uncovr-first-20-clinical-cases2026-09-04T08:38:16Z https://sofinnovapartners.com/news/moon-surgical-announces-first-clinical-cases-in-the-u-s-using-maestro-system2026-06-12T15:37:39Z https://sofinnovapartners.com/news/sofinnova-partners-nvidia-collaborate-unleash-supercomputing-power2026-09-04T08:38:16Z https://sofinnovapartners.com/news/dmc-biotechnologies-appoints-industry-veteran-k-lynne-johnson-as-chair-of-the-board2026-06-29T09:45:10Z https://sofinnovapartners.com/news/mission-therapeutics-raises-gbp25-2-million2026-09-04T08:38:16Z https://sofinnovapartners.com/portfolio/home-biosciences2022-01-03T11:31:25Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-two-new-partners-team-next-generation2026-09-04T08:38:16Z https://sofinnovapartners.com/news/qorium-bolsters-board-appointment-elizabeth-bastoni-martin-brok2026-09-04T08:38:16Z https://sofinnovapartners.com/news/inventiva-announces-the-nomination-of-andre-turenne-as-director2026-06-12T15:37:39Z https://sofinnovapartners.com/news/noema-pharma-fda-investigational-new-drug-authorization-phase-2b-study2026-09-04T08:38:16Z https://sofinnovapartners.com/news/biosyntia-raises-eur17-5-million-series-b2026-09-04T08:38:16Z https://sofinnovapartners.com/news/nanophoria-bioscience-publishes-groundbreaking-study-in-major-cardiology-journal2026-06-12T15:37:39Z https://sofinnovapartners.com/news/corriere-della-serra-interviews-graziano-seghezzi-after-sofinnova2026-09-04T08:38:16Z https://sofinnovapartners.com/news/mediar-therapeutics-initiates-second-clinical-program-portfolio2026-09-04T08:38:16Z https://sofinnovapartners.com/news/abivax-reports-excellent-one-year-efficacy-safety-data-abx464-phase-2b2026-09-04T08:38:16Z https://sofinnovapartners.com/news/abivax-full-exercise-underwriters-option-purchase-adss-bringing-gross2026-09-04T08:38:16Z https://sofinnovapartners.com/news/micropep-files-first-regulatory-submissions-promisin-tm-novel-peptide2026-09-04T08:38:16Z https://sofinnovapartners.com/news/artios-pharma-financial-leadership-appointment-christine-silverstein2026-09-04T08:38:16Z https://sofinnovapartners.com/team/matthieu-dreno2024-10-07T15:05:06Z https://sofinnovapartners.com/news/biotalys-announces-closing-of-private-placement2026-06-29T09:45:10Z https://sofinnovapartners.com/news/pyrowave-expands-microwave-technology-cement-decarbonization2026-09-04T08:38:16Z https://sofinnovapartners.com/news/amolyt-pharma-granted-fda-fast-track-designation-eneboparatide2026-09-04T08:38:16Z https://sofinnovapartners.com/team/alex-leech2025-12-16T22:13:08Z https://sofinnovapartners.com/news/sofinnova-partners-launches-collaboration-aws-scale-ai-across-life2026-09-04T08:38:16Z https://sofinnovapartners.com/news/asceneuron-joins-critical-path-for-alzheimer-s-disease-consortium2026-06-12T15:37:39Z https://sofinnovapartners.com/news/erydel-appoints-thomas-sabia-as-chief-commercial-officer2026-06-12T15:37:39Z https://sofinnovapartners.com/news/biotalys-starts-field-trials-for-second-biofungicide2026-06-12T15:37:42Z https://sofinnovapartners.com/news/the-keys-to-biotech-success-people-and-relationships2026-06-12T15:37:42Z https://sofinnovapartners.com/strategy/industrial-biotech2026-07-21T15:27:00Z https://sofinnovapartners.com/news/enginzyme-raises-eur21-million-series-b-accelerate-commercialisation2026-09-04T08:38:16Z https://sofinnovapartners.com/news/biotalys-receives-approval-large-scale-demonstration-trials-evoca2026-09-04T08:38:16Z https://sofinnovapartners.com/portfolio/glycoera2022-01-03T11:31:25Z https://sofinnovapartners.com/news/inspirna-partners-merck-kgaa-darmstadt-germany-accelerate-global2026-09-04T08:38:16Z https://sofinnovapartners.com/news/baxdrostat-met-primary-all-secondary-endpoints-baxhtn-phase-iii-trial2026-09-04T08:38:16Z https://sofinnovapartners.com/news/redx-nominates-gi-targeted-rock-inhibitor-rxc008-as-clinical-development-candidate2026-06-12T15:37:42Z https://sofinnovapartners.com/news/arzeda-kent-specialty-milling-strategic-product-development2026-09-04T08:38:16Z https://sofinnovapartners.com/portfolio/julier-medical2023-01-23T09:02:53Z https://sofinnovapartners.com/news/moon-surgical-appoints-chris-toth-independent-board-member-ahead2026-09-04T08:38:16Z https://sofinnovapartners.com/news/reflexion-expands-access-to-scintix-therapy-with-first-freestanding-cancer-center2026-06-12T15:37:42Z https://sofinnovapartners.com/news/sensorion-reports-six-month-update-audiogene-phase-1-2-trial-sens-5012026-09-04T08:38:16Z https://sofinnovapartners.com/news/noema-pharma-completion-enrollment-trigeminal-neuralgia-electronic2026-09-04T08:38:16Z https://sofinnovapartners.com/portfolio/microphyt2023-03-27T09:11:37Z https://sofinnovapartners.com/news/health-is-wealth-why-europe-must-act-now-to-strengthen-its-life-sciences-industry2026-06-29T09:08:21Z https://sofinnovapartners.com/news/sitryx-first-class-oral-pkm2-modulator-syx-5219-phase-1a-trial-data-be2026-09-04T08:38:16Z https://sofinnovapartners.com/news/calliditas-positive-topline-results-phase-2-head-neck-cancer-trial2026-09-04T08:38:16Z https://sofinnovapartners.com/news/aavantgarde-appoints-nina-ekaterini-kotsopoulou-phd-as-chief-technical-officer2026-06-12T15:37:42Z https://sofinnovapartners.com/news/aavantgarde-appointment-naveed-shams-m-d-ph-d-chief-development2026-09-04T08:38:16Z https://sofinnovapartners.com/news/sofinnova-partners-launches-biovelocita-first-pan-european-biotech-accelerator2026-09-04T08:38:16Z https://sofinnovapartners.com/news/sitryx-therapeutics-makes-key-appointments-strengthen-business2026-09-04T08:38:16Z https://sofinnovapartners.com/news/nephris-welcomes-discovery-of-novel-pathogenic-factor-in-diabetic-kidney-disease2026-06-12T15:37:42Z https://sofinnovapartners.com/news/maxcyte-launches-change-seq-be-and-one-seq-be-to-strengthen-off-target-assessment-for-genome-editing-therapies2026-09-04T08:44:04Z https://sofinnovapartners.com/news/corwave-appointment-dawn-sadlowski-buisserez-vice-president-operations2026-09-04T08:38:16Z https://sofinnovapartners.com/news/nodthera-publishes-preclinical-data-reversal-obesity-inflammation2026-09-04T08:38:16Z https://sofinnovapartners.com/news/sensorion-reports-new-positive-clinical-results-presented-world2026-09-04T08:38:16Z https://sofinnovapartners.com/portfolio/meiogenix2022-01-03T11:31:25Z https://sofinnovapartners.com/news/elicit-plant-announces-eur45-million-investment-round-to-accelerate-global-expansion2026-06-12T15:37:42Z https://sofinnovapartners.com/news/biotalys-appoints-laura-j-meyer-to-board-of-directors2026-06-12T15:37:42Z https://sofinnovapartners.com/news/f2g-shionogi-positive-topline-results-global-phase-3-oasis-study2026-09-04T08:38:19Z https://sofinnovapartners.com/news/elicit-plant-breakthrough-first-european-registration-obtained2026-09-04T08:38:19Z https://sofinnovapartners.com/news/aavantgarde-closes-usd141-million-series-b-financing2026-06-02T10:09:57Z https://sofinnovapartners.com/news/bioptimus-strengthens-commercial-and-scientific-leadership-with-key-hires2026-06-12T15:37:44Z https://sofinnovapartners.com/news/hemab-therapeutics-closing-upsized-initial-public-offering2026-09-04T08:38:19Z https://sofinnovapartners.com/portfolio/bioptimus2024-02-21T13:49:13Z https://sofinnovapartners.com/portfolio/cellcentric2026-05-06T14:08:34Z https://sofinnovapartners.com/news/sofinnova-welcomes-agnes-pauquet-as-head-of-human-resources2026-06-12T15:37:44Z https://sofinnovapartners.com/news/afyren-raises-eur23-million-through-share-capital-increase2026-09-04T08:38:19Z https://sofinnovapartners.com/news/how-a-sofinnova-partner-s-thesis-became-a-usd165m-biotech2026-06-24T11:53:35Z https://sofinnovapartners.com/news/redx-confirms-changes-to-board-composition2026-06-12T15:37:44Z https://sofinnovapartners.com/news/verley-becomes-first-company-receive-fda-no-questions-letter2026-09-04T08:38:19Z https://sofinnovapartners.com/news/proqr-therapeutics-usd8-1-million-new-funding-rett-syndrome-research2026-09-04T08:38:19Z https://sofinnovapartners.com/news/cellcentric-oversubscribed-usd220-million-series-d-financing2026-09-04T08:38:19Z https://sofinnovapartners.com/news/moon-surgical-receives-fda-clearance2026-09-04T08:38:19Z https://sofinnovapartners.com/portfolio/mnemo-therapeutics2022-01-03T11:31:25Z https://sofinnovapartners.com/news/mission-therapeutics-strikes-deal-worth-up-292-million-dimerix-ltd2026-09-04T08:38:19Z https://sofinnovapartners.com/news/deepc-acquires-osimis-platform-ai-infrastructure-radiology-scale2026-09-04T08:38:19Z https://sofinnovapartners.com/portfolio/abivax2022-01-03T11:31:25Z https://sofinnovapartners.com/news/noema-pharma-appoints-ilise-lombardo-m-d-as-chief-executive-officer2026-06-12T15:37:44Z https://sofinnovapartners.com/news/gensight-biologics-publication-matching-adjusted-indirect-comparison2026-09-04T08:38:19Z https://sofinnovapartners.com/news/noema-pharma-appoints-michael-samar-as-chief-financial-officer2026-06-12T15:37:44Z https://sofinnovapartners.com/news/mainstay-medical-exclusive-coverage-reactiv8-r-anthem-blue-cross-blue2026-09-04T08:38:19Z https://sofinnovapartners.com/news/disco-pharmaceuticals-appoints-mark-manfredi-ceo2026-09-04T08:38:19Z https://sofinnovapartners.com/portfolio/bionyra2026-06-22T09:59:07Z https://sofinnovapartners.com/news/sitryx-advances-development-pkm2-modulator-syx-5219-into-atopic2026-09-04T08:38:19Z https://sofinnovapartners.com/portfolio/novameat2024-09-12T05:56:27Z https://sofinnovapartners.com/news/artios-first-patient-dosed-randomized-phase-2-polka-study-evaluating2026-09-04T08:38:19Z https://sofinnovapartners.com/news/sofinnova-partners-raises-usd200m-digital-medicine-fund2026-06-12T15:37:44Z https://sofinnovapartners.com/news/redx-reports-encouraging-zamaporvint-rxc004-phase-2-combination-data2026-09-04T08:38:19Z https://sofinnovapartners.com/news/actithera-appoints-radiopharmaceutical-pioneer-dr-darshan-dalal-chief2026-09-04T08:38:19Z https://sofinnovapartners.com/news/sofinnova-partners-new-investment-nephris-biotech2026-09-04T08:38:19Z https://sofinnovapartners.com/news/corwave-announces-the-appointment-of-fairuz-hasni-as-vice-president-human-resources2026-06-12T15:37:44Z https://sofinnovapartners.com/news/noema-pharma-recruitment-first-patient-orpheus-phase-2b-study-pde10a2026-09-04T08:38:19Z https://sofinnovapartners.com/portfolio/nuage-therapeutics2023-06-20T10:20:52Z https://sofinnovapartners.com/news/mironid-extends-series-a-round-raising-gbp35-million-date-development2026-09-04T08:38:19Z https://sofinnovapartners.com/news/biocortex-raises-usd5-million-funding-led-sofinnova-partners-hoxton2026-09-04T08:38:19Z https://sofinnovapartners.com/news/signadori-bio-raises-eur11-million-seed-round-advance-next-generation2026-09-04T08:38:19Z https://sofinnovapartners.com/news/inventiva-announces-last-patient-visit-in-nativ3-phase-3-clinical-trial-of-lanifibranor-in-mash2026-09-04T09:23:39Z https://sofinnovapartners.com/regulatory-information2024-04-24T06:09:36Z https://sofinnovapartners.com/news/endoron-medical-awarded-eur2-5m-grant-european-commission-through2026-09-04T08:38:19Z https://sofinnovapartners.com/news/myricx-bio-announces-board-changes2026-06-29T09:45:10Z https://sofinnovapartners.com/portfolio/actithera2025-07-09T07:15:42Z https://sofinnovapartners.com/news/genespire-raises-eur46-6-million-usd52-million-series-b-round-advance2026-09-04T08:38:19Z https://sofinnovapartners.com/portfolio/cincor-pharma-inc2023-08-31T13:07:14Z https://sofinnovapartners.com/news/brightheart-secures-fda-clearance-first-ai-software-revolutionizing2026-09-04T08:38:19Z https://sofinnovapartners.com/news/moon-surgical-s-first-in-human-trials-detailed-in-article2026-06-12T15:37:47Z https://sofinnovapartners.com/news/pixium-vision-completion-implantations-european-pivotal-trial2026-09-04T08:38:19Z https://sofinnovapartners.com/portfolio/forth-therapeutics2025-03-18T05:08:24Z https://sofinnovapartners.com/news/afyren-announces-industrial-commissioning-of-plant-and-publishes-2021-annual-results2026-09-02T09:54:34Z https://sofinnovapartners.com/news/tissium-appoints-sara-toyloy-as-independent-board-member2026-06-12T15:37:47Z https://sofinnovapartners.com/portfolio/Excelsior Sciences2025-12-09T10:47:05Z https://sofinnovapartners.com/news/mainstay-medical-announces-ususd125-million-equity-financing-transaction2026-06-12T15:37:47Z https://sofinnovapartners.com/news/mission-therapeutics-raises-usd13-3-million2026-09-04T08:38:19Z https://sofinnovapartners.com/news/mainstay-medical-announces-exclusive-coverage-of-reactiv8-r-by-blue-cross-blue-shield2026-06-12T15:37:47Z https://sofinnovapartners.com/news/biotalys-novonesis-manufacturing-commercialisation-partnership-evoca2026-09-04T08:38:19Z https://sofinnovapartners.com/news/enginzyme-tetra-pak-join-forces-advance-sustainable-food-beverage2026-09-04T08:38:19Z https://sofinnovapartners.com/news/deepc-recognized-by-sofinnova-partners-as-a-top-performer-in-esg-excellence2026-06-12T15:37:47Z https://sofinnovapartners.com/news/noema-pharma-first-patient-dosed-phase-2a-study-noe-115-first-class2026-09-04T08:38:19Z https://sofinnovapartners.com/news/aavantgarde-first-patient-dosed-aavb-081-fih-phase-1-2-luce-1-study2026-09-04T08:38:19Z https://sofinnovapartners.com/news/nuage-therapeutics-welcomes-olivier-corminboeuf-blandine-guimet-their2026-09-04T08:38:19Z https://sofinnovapartners.com/news/muna-therapeutics-strategic-alliance-gsk-accelerate-development2026-09-04T08:38:19Z https://sofinnovapartners.com/news/sensorion-it-has-met-primary-endpoint-sens-401-phase-2a-clinical-study2026-09-04T08:38:19Z https://sofinnovapartners.com/news/mane-expands-partnership-arzeda-accelerate-global-commercialization2026-09-04T08:38:19Z https://sofinnovapartners.com/news/enhanced-data-security-quality-via-iso-27001-2022-soc-2-certifications2026-09-04T08:38:19Z https://sofinnovapartners.com/news/aavantgarde-receives-fda-ind-clearance-to-progress-stargardt-disease-program-aavb-0392026-06-02T14:03:50Z https://sofinnovapartners.com/news/asceneuron-secures-usd100-million-series-c-financing-advance2026-09-04T08:38:19Z https://sofinnovapartners.com/news/lilly-and-proqr-to-expand-rna-editing-collaboration2026-06-12T15:37:49Z https://sofinnovapartners.com/news/gensight-biologics-bolsters-regulatory-leadership-us-europe-two-senior2026-09-04T08:38:19Z https://sofinnovapartners.com/news/julier-medical-raises-eur3-million-seed-financing-sofinnova-partners2026-09-04T08:38:19Z https://sofinnovapartners.com/team/hadrien-pate2026-02-02T10:01:03Z https://sofinnovapartners.com/team/perrine-soupault2026-02-02T10:09:43Z https://sofinnovapartners.com/portfolio/arzeda2024-09-17T15:43:15Z https://sofinnovapartners.com/news/antoine-papiernik-and-sylvain-gariel-urge-france-to-invest-in-vaccines2026-06-12T15:37:49Z https://sofinnovapartners.com/news/gensight-biologics-appoints-william-monteith-to-its-board-of-directors2026-06-12T15:37:49Z https://sofinnovapartners.com/news/myricx-bio-gbp90m-usd114m-series-a-financing-advance-novel-nmti-adc2026-09-04T08:38:19Z https://sofinnovapartners.com/news/adapt-or-go-extinct-novameat-unveils-ingredient-will-save-global-meat2026-09-04T08:38:19Z https://sofinnovapartners.com/news/highlife-receives-iso-13485-certification-of-its-quality-management-system2026-06-12T15:37:49Z https://sofinnovapartners.com/news/safeheal-launch-safe-3cv-ide-study-colovac-anastomosis-protection2026-09-04T08:38:19Z https://sofinnovapartners.com/news/first-patients-treated-with-tissium-s-atraumatic-hernia-repair-system2026-06-12T15:37:49Z https://sofinnovapartners.com/news/ex-google-deepmind-owkin-scientists-team-up-create-bioptimus2026-09-04T08:38:19Z https://sofinnovapartners.com/news/baxdrostat-statistically-clinically-reduction-systolic-blood-pressure2026-09-04T08:38:19Z https://sofinnovapartners.com/news/sitryx-receives-fda-clearance-ind-application-syx-5219-treatment2026-09-04T08:38:19Z https://sofinnovapartners.com/news/moon-surgical-announces-ce-mark-for-its-commercial-maestro-system2026-06-12T15:37:49Z https://sofinnovapartners.com/strategy/telethon2026-07-21T15:41:34Z https://sofinnovapartners.com/news/biotalys-appoints-kamal-el-mernissi-as-chief-business-development-officer2026-06-12T15:37:49Z https://sofinnovapartners.com/news/les-echos-saving-french-biotech-antoine-papiernik2026-06-29T09:45:10Z https://sofinnovapartners.com/news/aavantgarde-closes-eur61-million-series-a-financing-advance-two2026-09-04T08:38:19Z https://sofinnovapartners.com/news/proqr-top-line-results-phase-2-3-illuminate-trial-sepofarsen-cep2902026-09-04T08:38:19Z https://sofinnovapartners.com/news/forth-tx-launches-backing-sofinnova-partners-revolutionize-fibrosis2026-09-04T08:38:19Z https://sofinnovapartners.com/news/bioptimus-appoints-julie-gerardi-as-chief-commercial-officer2026-06-02T14:05:23Z https://sofinnovapartners.com/news/cincor-pharma-appoints-marc-de-garidel-as-ceo2026-06-12T15:37:49Z https://sofinnovapartners.com/portfolio/cure-512024-08-20T08:41:45Z https://sofinnovapartners.com/news/artios-pharma-appoints-michael-t-andriole-ceo-director-advance2026-09-04T08:38:19Z https://sofinnovapartners.com/news/dr-neal-gutterson-joins-meiogenix-board2026-06-12T15:37:49Z https://sofinnovapartners.com/news/reflexion-announces-closing-of-usd125m-debt-facility-for-expanding-cancer-treatment2026-06-12T15:37:49Z https://sofinnovapartners.com/news/chroma-medicine-appoints-renowned-rna-scientist-melissa-moore-to-board-of-directors2026-06-12T15:37:52Z https://sofinnovapartners.com/news/nitrase-therapeutics-receives-new-grant-michael-j-fox-foundation2026-09-04T08:38:19Z https://sofinnovapartners.com/news/highlife-launches-new-large-annulus-valve-ongoing-clinical-studies2026-09-04T08:38:22Z https://sofinnovapartners.com/news/elicit-plant-appoints-pam-marrone-and-johan-de-saegher-to-its-board-of-directors2026-06-12T15:37:52Z https://sofinnovapartners.com/team/edward-kliphuis2026-02-02T10:17:13Z https://sofinnovapartners.com/news/tenpoint-therapeutics-ltd-fda-acceptance-new-drug-application2026-09-04T08:38:22Z https://sofinnovapartners.com/news/skidmore-owings-merrill-partners-prometheus-materials-design-zero2026-09-04T08:38:22Z https://sofinnovapartners.com/portfolio/nanophoria2024-08-08T13:49:56Z https://sofinnovapartners.com/team/aseem-ghaghda2025-04-15T14:09:46Z https://sofinnovapartners.com/news/highlife-appoints-prof-stephen-brecker-chief-medical-officer2026-06-12T15:37:52Z https://sofinnovapartners.com/news/sitryx-completes-enrollment-phase-1b-trial-first-class-oral-pkm22026-09-04T08:38:22Z https://sofinnovapartners.com/news/strategic-partnership-sustainable-agriculture-bayer-elicit-plant2026-09-04T08:38:22Z https://sofinnovapartners.com/news/welcome-to-our-new-website2026-06-12T15:37:52Z https://sofinnovapartners.com/portfolio/twentyeight-seven-therapeutics2023-06-09T04:32:27Z https://sofinnovapartners.com/portfolio/afyren2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/limflow2024-07-08T13:24:41Z https://sofinnovapartners.com/portfolio/corwave2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/inspirna-rgenix2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/corvidia-therapeutics-22022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/pixium2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/lysogene2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/synthace2025-10-09T10:21:06Z https://sofinnovapartners.com/portfolio/obseva2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/metgen2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/novexel2024-04-02T06:29:15Z https://sofinnovapartners.com/portfolio/ablynx-nv2024-04-02T06:32:45Z https://sofinnovapartners.com/portfolio/pyrowave2022-01-03T11:31:31Z https://sofinnovapartners.com/portfolio/nchroma-formerly-chroma-medicine2025-01-09T14:10:07Z https://sofinnovapartners.com/portfolio/gradient-denervation-technologies2024-02-26T11:02:46Z https://sofinnovapartners.com/team/henrijette-richter2026-02-02T10:53:11Z https://sofinnovapartners.com/team/graziano-seghezzi2025-12-16T22:02:05Z https://sofinnovapartners.com/team/jacques-theurillat2025-04-17T14:37:08Z https://sofinnovapartners.com/team/anne-osdoit2026-02-02T10:32:23Z https://sofinnovapartners.com/team/cedric-moreau2025-12-16T22:13:43Z https://sofinnovapartners.com/team/guillaume-baxter2026-02-02T10:46:26Z https://sofinnovapartners.com/team/gerard-hascoet2023-10-26T04:40:19Z https://sofinnovapartners.com/team/silvan-spinelli2023-12-13T09:50:32Z https://sofinnovapartners.com/team/christophe-blanche2025-12-16T22:16:42Z https://sofinnovapartners.com/team/armance-bordes2025-12-16T22:17:03Z https://sofinnovapartners.com/team/stephanie-huiban2024-08-05T14:58:39Z https://sofinnovapartners.com/team/thomas-bermudes2026-02-02T10:36:46Z https://sofinnovapartners.com/team/johanna-guacide2023-09-05T17:27:26Z https://sofinnovapartners.com/team/sandrine-le-penru2023-09-05T17:28:39Z https://sofinnovapartners.com/team/paola-pizzi2024-08-05T15:25:53Z https://sofinnovapartners.com/team/claire-catherinet2026-02-02T10:48:29Z https://sofinnovapartners.com/team/gabriella-camboni2026-02-02T10:18:53Z https://sofinnovapartners.com/team/antoine-papiernik2026-06-26T16:25:54Z https://sofinnovapartners.com/team/lucia-faccio2025-12-16T22:10:06Z https://sofinnovapartners.com/team/maina-bhaman2025-12-16T22:07:11Z https://sofinnovapartners.com/team/cecile-dupont2025-12-16T22:09:43Z https://sofinnovapartners.com/team/zhizhong-yao2026-02-02T10:42:13Z https://sofinnovapartners.com/team/martin-t-rothman2023-09-05T17:29:18Z https://sofinnovapartners.com/team/bertrand-echalard2024-08-05T14:53:21Z https://sofinnovapartners.com/team/juliette-grant2023-09-06T08:18:54Z https://sofinnovapartners.com/team/lamia-verney2023-09-05T17:26:08Z https://sofinnovapartners.com/team/joseph-anderson2025-12-16T22:06:51Z https://sofinnovapartners.com/team/aziliz-le-roux2025-06-27T13:51:09Z https://sofinnovapartners.com/strategy/digital-medicine2026-07-21T15:51:46Z https://sofinnovapartners.com/portfolio/kiro2023-03-27T17:49:16Z https://sofinnovapartners.com/news/bioptimus-launches-h-optimus-0-world-largest-open-source-ai-foundation2026-09-04T08:38:22Z https://sofinnovapartners.com/news/moon-surgical-unlocks-intelligent-or-maestro-connectivity-insights2026-09-04T08:38:22Z https://sofinnovapartners.com/news/moon-surgical-driving-robotics-into-high-volume-surgery2026-06-29T10:43:42Z https://sofinnovapartners.com/news/proqr-appoints-peter-a-beal-phd-as-chief-adar-scientist2026-06-12T15:37:52Z https://sofinnovapartners.com/news/proqr-leadership-appointments-cfo-cmo-support-next-phase-growth2026-09-04T08:38:22Z https://sofinnovapartners.com/news/nitrase-therapeutics-unveils-protein-newly-characterized-enzymatic2026-09-04T08:38:22Z https://sofinnovapartners.com/news/boehringer-ingelheim-licenses-novel-oral-therapeutics-program-immune2026-09-04T08:38:22Z https://sofinnovapartners.com/news/gradient-denervation-technologies-acceptance-into-fda-total-product2026-09-04T08:38:22Z https://sofinnovapartners.com/news/cincor-pharma-last-patient-randomized-phase-2-halo-trial-initiation2026-09-04T08:38:22Z https://sofinnovapartners.com/news/mission-therapeutics-awarded-usd5-2m-michael-j-fox-foundation2026-09-04T08:38:22Z https://sofinnovapartners.com/news/bioclec-launches-backing-sofinnova-partners-pioneer-breakthrough2026-09-04T08:38:22Z https://sofinnovapartners.com/news/abivax-reports-two-year-efficacy-safety-data-obefazimod-phase-2b2026-09-04T08:38:22Z https://sofinnovapartners.com/news/inventiva-sino-biopharm-licensing-collaboration-agreement-develop2026-09-04T08:38:22Z https://sofinnovapartners.com/news/brightheart-ce-mark-european-launch-ai-platform-prenatal-ultrasound2026-09-04T08:39:26Z https://sofinnovapartners.com/news/in-memory-of-denis-lucquin2026-06-29T09:45:10Z https://sofinnovapartners.com/news/gradient-denervation-technologies-closes-eur14m-series-a-led-by-sabadell-asabys2026-06-12T15:37:55Z https://sofinnovapartners.com/news/sofinnova-partners-enhances-leadership-in-medtech-acceleration-with-key-appointments2026-06-12T15:37:55Z https://sofinnovapartners.com/news/amid-buzz-jp-morgan-conference-sofinnova-partners-antoine-papiernik-is2026-09-04T08:38:22Z https://sofinnovapartners.com/news/sofinnova-partners-brings-dr-joshua-makower-stanford-biodesign-co2026-09-04T08:38:22Z https://sofinnovapartners.com/news/european-life-sciences-coalition-launched-strengthen-europe-life2026-09-04T08:38:22Z https://sofinnovapartners.com/team/daniel-sieiro2024-08-05T11:11:48Z https://sofinnovapartners.com/team/karl-naegler2026-05-19T16:38:06Z https://sofinnovapartners.com/news/aavantgarde-appoints-michael-heffernan-as-chairman-of-its-board-of-directors2026-06-12T15:37:55Z https://sofinnovapartners.com/news/sensorion-announces-leadership-changes2026-06-12T15:37:55Z https://sofinnovapartners.com/news/pincell-s-studies-open-up-new-indications-for-lead-candidate2026-06-12T15:37:55Z https://sofinnovapartners.com/news/highlife-receives-ce-mark-approval-for-its-tmvr-solution2026-06-29T09:45:10Z https://sofinnovapartners.com/team/pamela-putz2023-09-08T07:46:49Z https://sofinnovapartners.com/news/sitryx-collaboration-partner-lilly-has-commenced-phase-1-study-sit-0112026-09-04T08:38:22Z https://sofinnovapartners.com/news/pi-cardia-receives-fda-market-clearance-for-shortcut-tm2026-06-12T15:37:55Z https://sofinnovapartners.com/news/mane-arzeda-team-up-offer-next-gen-sugar-reduction-solutions-food2026-09-04T08:38:22Z https://sofinnovapartners.com/team/agnes-pauquet2024-10-15T07:00:13Z https://sofinnovapartners.com/features/2023-sofinnova-industrial-biotech-impact-report-a-hands-on-investment-strategy-driving-positive-change-for-the-planet2024-02-06T10:18:05Z https://sofinnovapartners.com/news/inari-medical-closes-acquisition-of-limflow2026-06-12T15:37:55Z https://sofinnovapartners.com/news/galvanize-therapeutics-receives-fda-clearance-aliya-ex-generator2026-09-04T08:38:22Z https://sofinnovapartners.com/news/aavantgarde-bio-fda-orphan-drug-designation-aavb-081-treatment-usher2026-09-04T08:38:22Z https://sofinnovapartners.com/portfolio/ingenix2026-06-03T07:22:43Z https://sofinnovapartners.com/news/sitryx-raises-usd39-million-fortherapeutics-for-chronic-autoimmune-and-inflammatory-disease2026-09-04T08:38:22Z https://sofinnovapartners.com/news/sitryx-initiates-phase-1-clinical-trial2026-09-04T08:38:22Z https://sofinnovapartners.com/news/nuage-therapeutics-raises-eur12m-seed-financing-led-sofinnova-partners2026-09-04T08:38:22Z https://sofinnovapartners.com/news/sofinnova-partners-unveils-sofinnova-ai-cutting-edge-ai2026-09-04T08:38:22Z https://sofinnovapartners.com/news/pyrowave-introduces-nanopurification-technology-short-loop-chemical2026-09-04T08:38:22Z https://sofinnovapartners.com/news/novameat-raises-eur17-4m-oversubscribed-series-a-round-led-sofinnova2026-09-04T08:38:22Z https://sofinnovapartners.com/news/qorium-lands-funds-brightlands-venture-partners-sofinnova-partners2026-09-04T08:38:22Z https://sofinnovapartners.com/news/abivax-reports-promising-abx464-phase-2a-one-year-maintenance-results2026-09-04T08:38:22Z https://sofinnovapartners.com/news/nanophoria-appoints-dr-suman-shirodkar-chair-prof-michael-davidson-non2026-09-04T08:38:22Z https://sofinnovapartners.com/news/sitryx-regains-rights-syx-1042-itaconate-mimetic-chronic-autoimmune2026-09-04T08:38:22Z https://sofinnovapartners.com/news/brightheart-eur2-million-seed-financing-sofinnova-partners-improve2026-09-04T08:38:22Z https://sofinnovapartners.com/news/pixium-vision-fda-breakthrough-device-designation-prima-system-dry-amd2026-09-04T08:38:22Z https://sofinnovapartners.com/news/tenpoint-therapeutics-secures-235-million-through-series-b2026-09-04T08:38:22Z https://sofinnovapartners.com/news/deepc-distribution-agreement-hyland-software-enhance-medical-imaging2026-09-04T08:38:22Z https://sofinnovapartners.com/news/freya-biosciences-usd38-million-funding-one-largest-series-a-raises2026-09-04T08:38:22Z https://sofinnovapartners.com/news/purespring-therapeutics-granted-european-medicines-agency-ema-orphan2026-09-04T08:38:22Z https://sofinnovapartners.com/news/seven-years-the-journey-behind-myricx-s-acquisition-by-novartis2026-07-14T11:04:11Z https://sofinnovapartners.com/news/prometheus-materials-raises-usd8-million-decarbonize-building-industry2026-09-04T08:38:22Z https://sofinnovapartners.com/news/glycoera-ag-raises-usd130-million-advance-novel-pipeline-extracellular2026-09-04T08:38:22Z https://sofinnovapartners.com/portfolio/may-health2024-01-29T15:23:53Z https://sofinnovapartners.com/news/pi-cardia-reports-first-commercial-cases-with-shortcut-tm2026-06-12T15:37:58Z https://sofinnovapartners.com/news/cure51-raises-eur15-million-seed-round-harness-natural-power-cancer2026-09-04T08:38:22Z https://sofinnovapartners.com/news/maestro-moon-surgical-s-rising-star2026-06-12T15:37:58Z https://sofinnovapartners.com/news/seghezzi-tells-unquote-after-apollo-deal-we-will-continue-build-our2026-09-04T08:38:22Z https://sofinnovapartners.com/news/cincor-pharma-announces-pricing-of-initial-public-offering2026-06-12T15:37:58Z https://sofinnovapartners.com/news/abivax-appoints-marc-de-garidel-as-chief-executive-officer-and-interim-board-chair2026-06-12T15:37:58Z https://sofinnovapartners.com/news/inspirna-appoints-dr-usman-oz-azam-m-d-as-new-chief-executive-officer2026-06-12T15:37:58Z https://sofinnovapartners.com/news/cincor-pharma-topline-data-phase-2-halo-trial-evaluating-selective2026-09-04T08:38:22Z https://sofinnovapartners.com/news/sofinnova-partners-raises-eur1-2-billion-fuel-next-wave-life-sciences2026-09-04T08:38:22Z https://sofinnovapartners.com/news/mnemo-therapeutics-names-robert-lacaze-as-ceo2026-06-12T15:37:58Z https://sofinnovapartners.com/news/calliditas-therapeutics-appoints-maria-toernsen-as-president-north-america2026-06-12T15:37:58Z https://sofinnovapartners.com/news/women-health-company-freya-biosciences-key-usd10-4-million-strategic2026-09-04T08:38:22Z https://sofinnovapartners.com/portfolio/tenpoint-therapeutics2023-07-12T10:40:16Z https://sofinnovapartners.com/news/bio-engineering-scale-up-qorium-showcases-cultivated-leather2026-09-04T08:38:22Z https://sofinnovapartners.com/news/f2g-receives-complete-response-letter-fda-new-drug-application2026-09-04T08:38:22Z https://sofinnovapartners.com/news/sensorion-eur50-5-million-financing2026-09-04T08:38:22Z https://sofinnovapartners.com/news/inventiva-positive-recommendation-third-dmc-phase-iii-clinical-trial2026-09-04T08:38:25Z https://sofinnovapartners.com/portfolio/corvent-medical2022-01-03T11:31:25Z https://sofinnovapartners.com/news/safeheal-appoints-medical-device-industry-veteran-chris-richardson2026-09-04T08:38:25Z https://sofinnovapartners.com/team/mariam-cherifi2024-08-05T10:35:46Z https://sofinnovapartners.com/news/mainstay-medical-positive-outcomes-restore-clinical-trial-reactiv82026-09-04T08:38:25Z https://sofinnovapartners.com/news/excelsior-sciences-raises-95-million-transform-small-molecule2026-09-04T08:38:25Z https://sofinnovapartners.com/news/prof-jacques-seguin-renowned-inventor-corevalve-joins-endoron-medical2026-09-04T08:38:25Z https://sofinnovapartners.com/news/cincor-pharma-doses-first-patient-phase-2-fightn-ckd-trial-evaluating2026-09-04T08:38:25Z https://sofinnovapartners.com/news/artios-oversubscribed-usd115-million-series-d-financing2026-09-04T08:38:25Z https://sofinnovapartners.com/news/catamaran-bio-appointment-michael-deridder-phd-senior-vice-president2026-09-04T08:38:25Z https://sofinnovapartners.com/features/2025-impact-report-industrial-biotech-delivering-impact2026-06-01T06:34:34Z https://sofinnovapartners.com/news/disco-pharmaceuticals-enters-license-agreement-advance-novel-cancer2026-09-04T08:38:25Z https://sofinnovapartners.com/news/sitryx-appoints-carrie-cook-as-chief-business-officer2026-06-12T15:38:00Z https://sofinnovapartners.com/news/sofinnova-partners-closes-650m-750m-capital-xi2026-09-04T08:38:25Z https://sofinnovapartners.com/news/abivax-oversubscribed-eur-130m-cross-over-financing-market-price-top2026-09-04T08:38:25Z https://sofinnovapartners.com/news/noema-pharma-founded-sofinnova-partners-raises-chf-103-million2026-09-04T08:38:25Z https://sofinnovapartners.com/team/antonin-weckel2024-09-27T19:29:49Z https://sofinnovapartners.com/news/tissium-strengthens-executive-leadership-team-with-key-appointments2026-06-12T15:38:00Z https://sofinnovapartners.com/news/tenpoint-therapeutics-united-kingdom-yuvezzi-submission-marketing2026-09-04T08:38:25Z https://sofinnovapartners.com/news/sofinnova-partners-exceeds-target-165m-biotech-acceleration-fund2026-09-04T08:38:25Z https://sofinnovapartners.com/news/gradient-denervation-technologies-appoints-stanton-rowe-to-board-receives-fda-approval-to-expand-feasibility-study2026-09-04T08:38:25Z https://sofinnovapartners.com/news/cecile-dupont-md-start-partner-selected-as-in-vivo-rising-leader2026-06-12T15:38:00Z https://sofinnovapartners.com/news/nodthera-oral-nlrp3-inhibitor-nt-0796-enhances-sustains-weight-loss2026-09-04T08:38:25Z https://sofinnovapartners.com/news/calliditas-therapeutics-full-fda-approval-tarpeyo2026-09-04T08:38:25Z https://sofinnovapartners.com/news/henrijette-richter-discusses-r-and-d-in-plenary-at-wuxi-global-forum2026-06-12T15:38:03Z https://sofinnovapartners.com/news/moon-surgical-raises-usd31-3-million-accelerate-development-maestro2026-09-04T08:38:25Z https://sofinnovapartners.com/news/meiogenix-hires-ricardo-garcia-alba-ceo-lead-company-through-growth-phase2026-09-04T08:38:25Z https://sofinnovapartners.com/news/chroma-medicine-secures-usd135m-series-b-financing-advance2026-09-04T08:38:25Z https://sofinnovapartners.com/news/inventiva-financing-up-eur348-million-advance-nativ3-phase-3-mash2026-09-04T08:38:25Z https://sofinnovapartners.com/news/catamaran-bio-preclinical-data-allogeneic-car-nk-cell-therapy-pipeline2026-09-04T08:38:25Z https://sofinnovapartners.com/news/recor-medical-otsuka-medical-devices-first-fda-approved-renal2026-09-04T08:38:25Z https://sofinnovapartners.com/news/pi-cardia-shortcut-tm-becomes-first-leaflet-modification-technology2026-09-04T08:38:25Z https://sofinnovapartners.com/portfolio/elicit-plant2022-08-01T14:20:09Z https://sofinnovapartners.com/news/mainstay-medical-announces-two-year-outcomes-from-restore-clinical-trial-of-reactiv82026-09-04T09:35:12Z https://sofinnovapartners.com/portfolio/p2-science2026-05-26T11:01:28Z https://sofinnovapartners.com/news/mainstay-medical-receipt-european-australian-approvals-mri-labeling2026-09-04T08:38:25Z https://sofinnovapartners.com/news/gfbiochemicals-raises-eur15m-series-a-advance-mission-end-chemical2026-09-04T08:38:25Z https://sofinnovapartners.com/news/afyren-chooses-thailand-for-second-biobased-organic-acids-plant-project-with-mitr-phol2026-09-04T08:38:25Z https://sofinnovapartners.com/portfolio/endoron-medical2023-11-22T13:32:07Z https://sofinnovapartners.com/news/antoine-papiernik-tells-le-figaro-apollo-deal-will-help-sofinnova2026-09-04T08:38:25Z https://sofinnovapartners.com/news/t-therapeutics-appoints-dr-david-hung-as-chairman2026-06-12T15:38:03Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-karl-naegler-as-partner2026-06-12T15:38:03Z https://sofinnovapartners.com/news/catamaran-bio-appoints-cherry-thomas-md-as-chief-medical-officer2026-06-12T15:38:03Z https://sofinnovapartners.com/news/calliditas-initiates-clinical-study-to-evaluate-setanaxib-in-alport-syndrome2026-06-12T15:38:03Z https://sofinnovapartners.com/news/nodthera-clinical-progress-lead-nlrp3-inflammasome-inhibitors2026-09-04T08:38:25Z https://sofinnovapartners.com/news/safeheal-receives-breakthrough-device-designation-colovac-endoluminal2026-09-04T08:38:25Z https://sofinnovapartners.com/news/nodthera-charts-obesity-future-first-patients-dosed-phase-2-resolve-12026-09-04T08:38:25Z https://sofinnovapartners.com/news/tissium-raises-eur50m-series-d-funding-finance-commercial-launch2026-09-04T08:38:25Z https://sofinnovapartners.com/news/cincor-pharma-appoints-june-lee-to-its-board-of-directors2026-06-12T15:38:05Z https://sofinnovapartners.com/news/nodthera-announces-appointment-of-daniel-swisher-as-chief-executive-officer2026-06-29T09:45:10Z https://sofinnovapartners.com/news/enginzyme-selected-cleantech-group-100-list2026-09-04T08:38:25Z https://sofinnovapartners.com/news/ashley-lakner-phd-joins-cure51-as-chief-scientific-officer-cso2026-06-02T15:15:31Z https://sofinnovapartners.com/portfolio/deepc2023-05-12T07:03:24Z https://sofinnovapartners.com/portfolio/biocortex2023-10-23T11:13:08Z https://sofinnovapartners.com/portfolio/l-ecole-ai2023-10-26T03:53:14Z https://sofinnovapartners.com/news/myricx-bio-clinical-team-us-presence-appointment-david-ellis-vp2026-09-04T08:38:25Z https://sofinnovapartners.com/news/safeheal-launch-pivotal-study-colovac-endoluminal-bypass-sheath2026-09-04T08:38:25Z https://sofinnovapartners.com/news/moon-surgical-maestro-system-powered-nvidia-holoscan2026-09-04T08:38:25Z https://sofinnovapartners.com/news/henrijette-richter-discusses-apollo-deal-with-borsen-you-have-to-play-in-that-arena2026-06-12T15:38:05Z https://sofinnovapartners.com/news/cincor-s-marc-de-garidel-building-things-has-been-my-specialty2026-06-12T15:38:05Z https://sofinnovapartners.com/news/afyren-fermentation-lab-reaches-2-million-hour-mark-it2026-09-04T08:38:25Z https://sofinnovapartners.com/news/noema-pharma-first-patients-dosed-phase-2b-study-gemlapodect-noe-1052026-09-04T08:38:25Z https://sofinnovapartners.com/news/haya-therapeutics-receives-fda-fast-track-designation-for-htx-0012026-07-31T10:40:33Z https://sofinnovapartners.com/news/muna-therapeutics-nature-medicine-publication-validating-microglial2026-09-04T08:38:25Z https://sofinnovapartners.com/news/afyren-inaugurates-its-first-factory-afyren-neoxy-a-first-of-its-kind-biorefinery2026-06-12T15:38:05Z https://sofinnovapartners.com/news/inventiva-provides-update-nativ3-clinical-program2026-09-04T08:38:25Z https://sofinnovapartners.com/news/moon-surgical-receives-first-fda-510-k-clearance-maestro-tm-surgical2026-09-04T08:38:25Z https://sofinnovapartners.com/news/artios-pharma-bolsters-board-of-directors-with-appointment-of-chris-liu-phd2026-06-12T15:38:05Z https://sofinnovapartners.com/news/endoron-medical-raises-usd10-million-series-a-funding-led-sofinnova2026-09-04T08:38:25Z https://sofinnovapartners.com/news/microphyt-raises-eur15-million-to-accelerate-commercialization-microalgae2026-09-04T08:38:25Z https://sofinnovapartners.com/news/micropep-ag-biotech-innovator-raises-eur8-75-million-global-syndicate2026-09-04T08:38:25Z https://sofinnovapartners.com/news/sofinnova-partners-gustave-roussy-launch-first-biotech-company-through2026-09-04T08:38:25Z https://sofinnovapartners.com/news/cincor-pharma-positive-topline-data-phase-2-brightn-trial-evaluating2026-09-04T08:38:25Z https://sofinnovapartners.com/portfolio/nephris2022-04-20T06:37:45Z https://sofinnovapartners.com/news/genespire-appoints-karen-aiach-pignet-as-chief-executive-officer2026-06-29T09:45:10Z https://sofinnovapartners.com/news/amolyt-pharma-usd138-million-series-c-financing-led-sofinnova-partners2026-09-04T08:38:25Z https://sofinnovapartners.com/news/inspirna-raises-usd50-million-in-series-d-financing2026-06-12T15:38:08Z https://sofinnovapartners.com/news/catamaran-bio-expands-collaboration-car-nk-cell-engineering-university2026-09-04T08:38:25Z https://sofinnovapartners.com/news/hemab-therapeutics-usd157-million-series-c-financing-advance-next2026-09-04T08:38:25Z https://sofinnovapartners.com/news/may-health-completes-treatment-five-participants-u-feasibility-study2026-09-04T08:38:25Z https://sofinnovapartners.com/news/limflow-announces-agreement-to-be-acquired-by-inari-medical2026-06-12T15:38:08Z https://sofinnovapartners.com/features/Sofinnova-industrial-biotech-impact-report-20222024-02-02T10:22:21Z https://sofinnovapartners.com/portfolio/Purespring2024-10-09T11:15:03Z https://sofinnovapartners.com/news/one-biosciences-eur15-million-series-a-financing-advance-clinical2026-09-04T08:38:28Z https://sofinnovapartners.com/news/biotalys-achieves-first-milestone-in-bioinsecticide-partnership-with-syngenta2026-06-29T09:45:10Z https://sofinnovapartners.com/portfolio/latent-labs2025-02-13T08:02:23Z https://sofinnovapartners.com/portfolio/Galvanize2026-05-19T16:40:19Z https://sofinnovapartners.com/news/jazz-pharmaceuticals-enters-definitive-agreement-redx-pharma-acquire2026-09-04T08:38:28Z https://sofinnovapartners.com/news/latent-labs-aws-collaboration-scale-generative-ai-life-sciences2026-09-04T08:38:28Z https://sofinnovapartners.com/news/nanophoria-bioscience-awarded-eur17-5-m-european-innovation-council2026-09-04T08:38:28Z https://sofinnovapartners.com/news/dna-script-expands-leadership-team-appointment-madoo-varma2026-09-04T08:38:28Z https://sofinnovapartners.com/news/hotspot-therapeutics-appoints-niti-goel-m-d-as-chief-medical-officer2026-08-19T17:32:22Z https://sofinnovapartners.com/news/mission-therapeutics-commences-trial-mtx325-potential-disease2026-09-04T08:38:28Z https://sofinnovapartners.com/news/sofinnova-partners-welcomes-andrew-m-weiss-as-venture-partner2026-06-12T15:38:08Z https://sofinnovapartners.com/news/mediar-therapeutics-doses-first-patient-phase-2-wisper-trial-mtx-4632026-09-04T08:38:28Z https://sofinnovapartners.com/news/abivax-provides-business-and-operational-update2026-06-12T15:38:08Z https://sofinnovapartners.com/news/gensight-biologics-announces-a-successful-offering-for-an-amount-over-eur9-2-million2026-06-03T07:09:41Z https://sofinnovapartners.com/news/abivax-announces-closing-of-920-million-public-offering2026-07-14T13:41:59Z https://sofinnovapartners.com/news/nodthera-appoints-geoff-mcdonough-m-d-as-chief-executive-officer2026-06-29T09:45:10Z https://sofinnovapartners.com/news/fmc-corporation-micropep-technologies-strategic-collaboration2026-09-04T08:38:28Z https://sofinnovapartners.com/features/impact-accountability-in-venture-capital-a-ready-reference-for-practitioners2025-01-09T13:18:01Z https://sofinnovapartners.com/news/bioptimus-stela-world-largest-clinically-linked-spatial-biology-atlas2026-09-04T08:38:28Z https://sofinnovapartners.com/news/qureight-support-mediar-therapeutics-phase-2-trial2026-09-04T08:38:28Z https://sofinnovapartners.com/news/sensorion-achieves-key-regulatory-milestones-sens-601-gjb2-related2026-09-04T08:38:28Z https://sofinnovapartners.com/news/biontech-crescendo-biologics-global-collaboration2026-09-04T08:38:28Z https://sofinnovapartners.com/news/catamaran-bio-appoints-frank-lee-as-chair-of-its-board-of-directors2026-06-12T15:38:08Z https://sofinnovapartners.com/news/is-there-a-lack-of-european-late-stage-capital2026-06-12T15:38:08Z https://sofinnovapartners.com/news/exmoor-pharma-signadori-bio-launch-partnership-develop-next-generation2026-09-04T08:38:28Z https://sofinnovapartners.com/news/brightheart-obtains-third-fda-clearance-for-real-time-fetal-heart-detection2026-09-04T08:38:28Z https://sofinnovapartners.com/news/may-health-raises-usd25-million-series-b-funding-advance-development2026-09-04T08:38:28Z https://sofinnovapartners.com/news/brightheart-raises-11m-series-a-scale-expert-level-ai-platform2026-09-04T08:38:28Z https://sofinnovapartners.com/team/fourati-ahmed2024-08-05T14:57:53Z https://sofinnovapartners.com/news/sitryx-partner-lilly-exercises-option-sit-011-chronic-autoimmune2026-09-04T08:38:28Z https://sofinnovapartners.com/news/proqr-announces-cta-submission-for-phase-1-study-of-ax-0810-targeting-ntcp2026-06-02T14:01:44Z https://sofinnovapartners.com/news/genespire-sr-tiget-show-durable-preclinical-efficacy-gene-therapy2026-09-04T08:38:28Z https://sofinnovapartners.com/portfolio/freya-biosciences2023-12-12T13:54:06Z https://sofinnovapartners.com/portfolio/mediar-therapeutics2024-08-07T12:40:15Z https://sofinnovapartners.com/news/f2g-data-phase-2b-study-id-week-2022-positive-therapeutic-response2026-09-04T08:38:28Z https://sofinnovapartners.com/news/noema-pharma-appoints-michael-gutch-as-chief-financial-officer2026-06-12T15:38:11Z https://sofinnovapartners.com/news/elicit-plant-makes-c-and-en-s-list-of-10-start-ups-to-watch2026-06-12T15:38:11Z https://sofinnovapartners.com/news/mediar-therapeutics-enters-into-global-licensing-agreement-lilly2026-09-04T08:38:28Z https://sofinnovapartners.com/news/antoine-papiernik-speaks-at-growing-together-athens-event2026-06-12T15:38:11Z https://sofinnovapartners.com/news/moon-surgical-appoints-anne-renevot-as-chief-financial-officer2026-06-12T15:38:11Z https://sofinnovapartners.com/news/galvanize-therapeutics-announces-the-latest-exploratory-evidence-suggesting-immune-activating-potential-of-aliya-pef-energy2026-09-04T09:01:11Z https://sofinnovapartners.com/news/afyren-provides-business-update-on-its-afyren-neoxy-plant2026-06-12T15:38:11Z https://sofinnovapartners.com/news/simon-turner-talks-digital-medicine-at-lsi-usa-232026-06-12T15:38:11Z https://sofinnovapartners.com/news/sensorion-new-positive-secondary-ecacy-endpoints-data-sens-401-phase2026-09-04T08:38:28Z https://sofinnovapartners.com/news/sitryx-nominates-novel-oral-and-targeted-pkm2-activator-for-atopic-dermatitis2026-09-04T08:38:28Z https://sofinnovapartners.com/news/actithera-raises-usd75-5m-oversubscribed-series-a-financing2026-09-04T08:38:28Z https://sofinnovapartners.com/news/arnault-tzanck-institute-nice-france-completes-inaugural-robotics2026-09-04T08:38:28Z https://sofinnovapartners.com/news/abivax-completion-enrollment-phase-3-abtect-trials-patients-moderately2026-09-04T08:38:28Z https://sofinnovapartners.com/news/sensorion-eur15-million-financing-extending-cash-runway-until-end-20252026-09-04T08:38:28Z https://sofinnovapartners.com/news/prometheus-materials-secures-multiple-astm-certifications2026-09-04T08:38:28Z https://sofinnovapartners.com/portfolio/Signadori Bio2025-07-04T17:43:17Z https://sofinnovapartners.com/news/noema-pharma-first-patient-dosed-phase-2b-libratn-study-mglur52026-09-04T08:38:28Z https://sofinnovapartners.com/news/inventiva-pricing-upsized-public-offering-approximately-150m2026-09-04T08:38:28Z https://sofinnovapartners.com/news/sensorion-eur60-million-financing-eur20m-strategic-investment-sanofi2026-09-04T08:38:28Z https://sofinnovapartners.com/news/mozart-therapeutics-positive-interim-phase-1-data-adults-stage-3-type2026-09-04T08:38:28Z https://sofinnovapartners.com/news/elicit-plant-raises-eur16m-accelerate-r-d-marketing-natural-solution2026-09-04T08:38:28Z https://sofinnovapartners.com/news/biotalys-and-agrofresh-partner-to-protect-fresh-produce2026-06-02T14:16:36Z https://sofinnovapartners.com/news/elicit-plant-appointment-slavica-djonovic-ph-d-chief-scientific2026-09-04T08:38:28Z https://sofinnovapartners.com/team/martina-epi2026-02-02T10:12:20Z https://sofinnovapartners.com/news/avantium-and-carlsberg-sign-offtake-agreement-on-pef2026-06-12T15:38:14Z https://sofinnovapartners.com/news/aavantgarde-founder-alberto-auricchio-elected-vice-president-european-society-of-gene-and-cell-therapy2026-09-04T08:38:28Z https://sofinnovapartners.com/news/moon-surgical-expands-maestro-platform-into-multi-model-physical-ai2026-09-04T08:38:28Z https://sofinnovapartners.com/news/introducing-latent-x-frontier-generative-ai-model-protein-binder2026-09-04T08:38:28Z https://sofinnovapartners.com/portfolio/haya-therapeutics2025-05-08T12:28:10Z https://sofinnovapartners.com/team/pauline-roca2025-07-07T14:56:02Z https://sofinnovapartners.com/news/artios-leadership-team-accelerate-late-stage-development-potential2026-09-04T08:38:28Z https://sofinnovapartners.com/news/world-first-cancer-patient-treated-reflexion-breakthrough-scintix2026-09-04T08:38:28Z https://sofinnovapartners.com/news/recor-medical-otsuka-medical-devices-primary-endpoint-met-radiance-ii2026-09-04T08:38:28Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-mats-eklund-as-partner-and-chief-operating-officer2026-06-12T15:38:14Z https://sofinnovapartners.com/news/aavantgarde-appoints-dr-doug-kerr-to-the-board-of-directors2026-06-12T15:38:14Z https://sofinnovapartners.com/news/sensorion-announces-approval-of-clinical-trial-application-in-france-for-sens-601-its-investigational-gene-therapy-for-the-treatment-of-gjb2-related-hearing-loss2026-09-04T10:09:33Z https://sofinnovapartners.com/news/brightheart-voluson-tm-solution-store-collaboration2026-09-04T08:38:28Z https://sofinnovapartners.com/news/afyren-resumption-production-plant-after-technical-shutdown2026-09-04T08:38:28Z https://sofinnovapartners.com/news/tenpoint-therapeutics-positive-topline-data-phase-3-pivotal-study-brio2026-09-04T08:38:28Z https://sofinnovapartners.com/news/pixium-vision-implantation-first-patient-netherlands-prima-system2026-09-04T08:38:28Z https://sofinnovapartners.com/news/sofinnova-partners-focus-on-people-and-science-at-the-core-of-investment-strategy2026-06-12T15:38:14Z https://sofinnovapartners.com/news/noema-pharma-receives-fda-fast-track-designation-basimglurant-noe-1012026-09-04T08:38:28Z https://sofinnovapartners.com/news/muna-therapeutics-first-subjects-dosed-phase-1-trial-novel-oral-trem22026-09-04T08:38:28Z https://sofinnovapartners.com/news/inventiva-positive-results-phase-ii-legend-proof-concept-study2026-09-04T08:38:28Z https://sofinnovapartners.com/news/chroma-medicine-exclusive-license-agreement-whitehead-institute-novel2026-09-04T08:38:31Z https://sofinnovapartners.com/news/elevara-medicines-raises-usd70-million-series-a-advance-phase-22026-09-04T08:38:31Z https://sofinnovapartners.com/news/brightheart-unveils-breakthrough-ai-fetal-medicine-results2026-09-02T09:55:43Z https://sofinnovapartners.com/portfolio/gensight-biologics2024-07-10T10:07:58Z https://sofinnovapartners.com/news/sofinnova-partners-charging-ahead-in-italy2026-06-12T15:38:14Z https://sofinnovapartners.com/news/enginzyme-produces-key-mrna-vaccine-ingredient-using-biocatalysis2026-06-12T15:38:14Z https://sofinnovapartners.com/news/myricx-pharma-senior-team-expansion2026-09-04T08:38:31Z https://sofinnovapartners.com/news/myricx-bio-expansion-leadership-team-advance-nmti-adcs-into-clinical2026-09-04T08:38:31Z https://sofinnovapartners.com/news/sensorion-submits-clinical-trial-application-otof-gt-lead-gene-therapy2026-09-04T08:38:31Z https://sofinnovapartners.com/news/sensorion-announces-the-appointment-of-laurene-danon-as-chief-financial-officer2026-06-29T09:45:10Z https://sofinnovapartners.com/news/abivax-pricing-initial-public-offering-nasdaq-global-market2026-09-04T08:38:31Z https://sofinnovapartners.com/news/reflexion-receives-fda-clearance-scintix-biology-guided-radiotherapy2026-09-04T08:38:31Z https://sofinnovapartners.com/portfolio/advanced-perfusion-diagnostics2022-01-03T11:31:26Z https://sofinnovapartners.com/portfolio/aavantgarde-bio2022-01-03T11:31:26Z https://sofinnovapartners.com/news/p2-science-closes-usd23-million-round-accelerate-commercial-momentum2026-09-04T08:38:31Z https://sofinnovapartners.com/news/syngenta-leverage-biotalys-agrobody-tm-technology-platform-expand2026-09-04T08:38:31Z https://sofinnovapartners.com/news/nodthera-reversal-neuroinflammation-inflammation-parkinson-disease2026-09-04T08:38:31Z https://sofinnovapartners.com/news/inventiva-ind-application-phase-ii-combination-trial-lanifibranor2026-09-04T08:38:31Z https://sofinnovapartners.com/news/inventiva-secures-new-patent-japan-expanding-ip-protection2026-09-04T08:38:31Z https://sofinnovapartners.com/news/f2g-fda-filing-acceptance-new-drug-application-olorofim-treatment2026-09-04T08:38:31Z https://sofinnovapartners.com/news/15-20-national-hospital-gensight-biologics-treatment-first-patient2026-09-04T08:38:31Z https://sofinnovapartners.com/news/amolyt-pharma-phase-3-clinical-trial-eneboparatide-treatment2026-09-04T08:38:31Z https://sofinnovapartners.com/news/myricx-bio-appoints-dr-chris-martin-biotech-entrepreneur-adc-pioneer2026-09-04T08:38:31Z https://sofinnovapartners.com/news/acquisition-of-cincor-pharma-complete2026-06-12T15:38:16Z https://sofinnovapartners.com/news/sofinnova-henrijette-richter-talks-biocentury-about-creating-support2026-09-04T08:38:31Z https://sofinnovapartners.com/news/genespire-appoints-dr-sabah-sallah-as-chief-medical-officer2026-06-12T15:38:16Z https://sofinnovapartners.com/news/sensorion-positive-recommendation-data-safety-monitoring-board-dsmb2026-09-04T08:38:31Z https://sofinnovapartners.com/news/bon-vivant-achieves-self-affirmed-gras-status-notifying-fda2026-09-04T08:38:31Z https://sofinnovapartners.com/news/mediar-therapeutics-clinical-candidates-lead-fibrosis-programs2026-09-04T08:38:31Z https://sofinnovapartners.com/news/highlife-granted-us-fda-breakthrough-device-designation-for-its-tmvr-solution2026-06-12T15:38:16Z https://sofinnovapartners.com/news/brightheart-obtains-second-fda-clearance-expansion-platform2026-09-04T08:38:31Z https://sofinnovapartners.com/news/myricx-bio-enters-into-an-exclusive-antibody-license-agreement-with-wuxi-biologics2026-06-12T15:38:16Z https://sofinnovapartners.com/features/healthcare-in-the-post-covid-era-where-is-cell-and-gene-therapy-going2025-03-04T09:42:57Z https://sofinnovapartners.com/portfolio/sensorion2022-01-03T11:31:26Z https://sofinnovapartners.com/news/crescendo-biologics-first-u-patients-dosed-expanded-phase-1b-clinical2026-09-04T08:38:31Z https://sofinnovapartners.com/news/alia-therapeutics-secures-eur4-4-million-seed-financing-extension-led2026-09-04T08:38:31Z https://sofinnovapartners.com/news/danone-dmc-michelin-credit-agricole-centre-france-join-forces-create2026-09-04T08:38:31Z https://sofinnovapartners.com/news/sensorion-appoints-fred-chereau-as-chief-executive-officer2026-06-12T15:38:19Z https://sofinnovapartners.com/news/inventiva-draws-down-second-tranche-eur25-million2026-09-04T08:38:31Z https://sofinnovapartners.com/news/tissium-first-commercial-use-coaptium-r-connect-peripheral-nerve2026-09-04T08:38:31Z https://sofinnovapartners.com/portfolio/pi-cardia2022-01-03T11:31:26Z https://sofinnovapartners.com/news/mission-therapeutics-granted-mhra-clinical-trial-authorisation-cta2026-09-04T08:38:31Z https://sofinnovapartners.com/news/mablink-bioscience-enters-an-agreement-to-be-acquired-by-lilly2023-10-19T07:37:46Z https://sofinnovapartners.com/news/mainstay-medical-publication-first-neuromodulation-study-low-back-pain2026-09-04T08:38:31Z https://sofinnovapartners.com/portfolio/f2g2022-08-04T07:09:17Z https://sofinnovapartners.com/news/pi-cardia-receives-fda-ide-approval-for-pivotal-study-with-shortcut-tm-device2026-06-12T15:38:19Z https://sofinnovapartners.com/news/dmc-appoints-kelly-smith-as-vp-r-and-d2026-06-12T15:38:19Z https://sofinnovapartners.com/news/mironid-r-appoints-dr-catherine-kelleher-as-chief-medical-officer2026-06-12T15:38:19Z https://sofinnovapartners.com/news/sitryx-announces-leadership-transition2026-06-12T15:38:19Z https://sofinnovapartners.com/news/amolyt-pharma-initiation-phase-1-clinical-trial-peptide-growth-hormone2026-09-04T08:38:31Z https://sofinnovapartners.com/news/may-health-solidifies-veteran-executive-team-appointment-women-health2026-09-04T08:38:31Z https://sofinnovapartners.com/news/inari-medical-expands-its-patient-focused-mission-with-agreement-to-acquire-limflow2026-06-12T15:38:19Z https://sofinnovapartners.com/news/germany-top-research-institutions-venture-capital-investors-unite2026-09-04T08:38:31Z https://sofinnovapartners.com/news/f2g-moves-uk-headquarters-to-mediacity2026-06-12T15:38:19Z https://sofinnovapartners.com/news/moon-surgical-appoints-fred-moll-md-board-chair-raises-usd55-4-million2026-09-04T08:38:31Z https://sofinnovapartners.com/news/inventiva-positive-recommendation-fourth-dmc-nativ3-phase-iii-clinical2026-09-04T08:38:31Z https://sofinnovapartners.com/news/sensorion-us-fda-grants-rare-pediatric-disease-designation-otof-gt2026-09-04T08:38:31Z https://sofinnovapartners.com/team/cristina-pelizon2025-04-15T14:10:39Z https://sofinnovapartners.com/news/sofinnova-partners-and-apollo-form-strategic-partnership-in-life-sciences2026-06-12T15:38:19Z https://sofinnovapartners.com/news/qorium-secures-22m-investment-to-accelerate-cultivated-leather-commercialisation2026-06-29T09:45:10Z https://sofinnovapartners.com/news/purespring-therapeutics-appoints-haseeb-ahmad-as-chief-executive-officer2026-06-12T15:38:19Z https://sofinnovapartners.com/news/gender-diversity-in-venture-capital-visible-and-invisible-barriers-slow-progress2026-06-12T15:38:22Z https://sofinnovapartners.com/news/biosyntia-closes-a-eur11-5-million-round-to-launch-world-s-first-bio-based-vitamin-b72026-06-12T15:38:22Z https://sofinnovapartners.com/portfolio/precardia2022-01-03T11:31:26Z https://sofinnovapartners.com/news/sitryx-appoints-adam-mostafa-as-chief-financial-officer2026-06-12T15:38:22Z https://sofinnovapartners.com/news/glycoera-ag-raises-chf-45-million-us-49-million-series-a-financing2026-09-04T08:38:31Z https://sofinnovapartners.com/news/geraldine-usseglio-joins-sofinnova-partners-as-head-of-human-resources2026-06-12T14:12:19Z https://sofinnovapartners.com/news/sofinnova-partners-closes-63m-75m-oversubscribed-medtech-acceleration-fund2026-06-03T16:07:38Z https://sofinnovapartners.com/news/mainstay-medical-announces-reimbursement-approval-for-reactiv8-in-australia2026-05-28T09:13:43Z https://sofinnovapartners.com/news/shockwave-medical-cms-has-created-new-codes-intravascular-lithotripsy2026-09-04T08:38:31Z https://sofinnovapartners.com/news/calliditas-therapeutics-prices-initial-public-offering-nasdaq-global2026-09-04T08:38:31Z https://sofinnovapartners.com/news/nodthera-announces-close-of-55-million-series-b-financing2026-06-12T15:38:22Z https://sofinnovapartners.com/news/rgenix-clinical-activity-novel-agent-rgx-202-patients-kras-mutant2026-09-04T08:38:31Z https://sofinnovapartners.com/news/reflexion-clinical-collaboration-evaluate-biology-guided-radiotherapy2026-09-04T08:38:31Z https://sofinnovapartners.com/news/biotalys-awarded-1-6-million-vlaio-research-grant2026-06-29T09:45:10Z https://sofinnovapartners.com/news/abivax-german-regulatory-approval-abx464-covid-19-phase-2b-3-covid-192026-09-04T08:38:31Z https://sofinnovapartners.com/news/comet-bio-announces-positive-clinical-trial-results-for-its-prebiotic-arrabin2026-06-12T15:38:22Z https://sofinnovapartners.com/news/hotspot-therapeutics-completes-65-million-series-b-financing2026-09-04T08:38:31Z https://sofinnovapartners.com/news/muna-therapeutics-launches-us-73m-series-a2026-09-04T08:38:31Z https://sofinnovapartners.com/news/abivax-receives-ansm-ethics-committee-clearance-test-development2026-09-04T08:38:31Z https://sofinnovapartners.com/news/abx464-inhibits-replication-sars-cov-2-covid-19-reconstituted-human2026-09-04T08:38:31Z https://sofinnovapartners.com/news/genespire-sr-tiget-strategic-alliance-development-transformative-gene2026-09-04T08:38:31Z https://sofinnovapartners.com/news/corvent-medical-coridea-portfolio-company-closes-4-5m-seed-financing2026-09-04T08:38:31Z https://sofinnovapartners.com/news/pincell-appoints-veteran-biotech-biopharma-executives-management-team2026-09-04T08:38:31Z https://sofinnovapartners.com/news/biotalys-first-biocontrol-proves-consistent-high-efficacy-global-fruit2026-09-04T08:38:31Z https://sofinnovapartners.com/news/verona-pharma-presents-expanded-analysis-ensifentrine-clinical-data2026-09-04T08:38:31Z https://sofinnovapartners.com/news/pyrowave-closes-series-b-led-by-michelin-and-sofinnova-partners2026-06-12T15:38:24Z https://sofinnovapartners.com/news/genespire-secures-e16-million-series-a-financing-sofinnova-partners2026-09-04T08:38:31Z https://sofinnovapartners.com/news/enginzyme-secures-6-4-million-series-a-financing-round-led-by-sofinnova-partners2026-06-29T09:45:10Z https://sofinnovapartners.com/news/micropep-raises-eur-8-5m-usd-10m-oversubscribed-series-a-financing2026-09-04T08:38:35Z https://sofinnovapartners.com/news/nitrome-biosciences-raises-38m-series-a-financing-advance-therapeutics2026-09-04T08:38:35Z https://sofinnovapartners.com/news/sofinnova-partners-announces-third-investment-from-its-italian-fund2026-06-12T15:38:24Z https://sofinnovapartners.com/news/pi-cardia-closes-27-million-financing-led-sofinnova-partners2026-09-04T08:38:35Z https://sofinnovapartners.com/news/biotalys-establishes-scientific-advisory-board2026-06-12T15:38:24Z https://sofinnovapartners.com/news/reflexion-raises-100-million-for-cancer-treatment-commercialization2026-06-12T15:38:24Z https://sofinnovapartners.com/news/gensight-biologics-track-submit-lumevoq-european-approval-september2026-09-04T08:38:35Z https://sofinnovapartners.com/news/erydel-completion-patient-enrollment-phase-3-attest-trial-largest2026-09-04T08:38:35Z https://sofinnovapartners.com/news/shockwave-completes-enrollment-of-coronary-intravascular-lithotripsy-study-in-japan2026-06-12T15:38:24Z https://sofinnovapartners.com/news/calliditas-appoints-new-chief-medical-officer2026-06-12T15:38:24Z https://sofinnovapartners.com/news/reflexion-announces-first-sale-of-x1-machine-for-cancer-treatment2026-06-12T15:38:24Z https://sofinnovapartners.com/news/biotalys-announces-successful-54-6-million-initial-public-offering2026-06-29T09:45:10Z https://sofinnovapartners.com/news/shockwave-completes-enrollment-pivotal-study-coronary-intravascular2026-09-04T08:38:35Z https://sofinnovapartners.com/news/tissium-receives-ce-mark-manufacturing-compliance-certification-tuv2026-09-04T08:38:35Z https://sofinnovapartners.com/news/calliditas-strengthens-its-us-commercial-organization2026-06-12T15:38:24Z https://sofinnovapartners.com/news/pixium-vision-announces-positive-follow-up-data-from-prima-system-study-in-dry-amd2026-06-12T15:38:24Z https://sofinnovapartners.com/news/proqr-positive-findings-interim-analysis-phase-1-2-trial-qr-421a-usher2026-09-04T08:38:35Z https://sofinnovapartners.com/news/lilly-sitryx-licensing-research-collaboration2026-09-04T08:38:35Z https://sofinnovapartners.com/news/fda-clearance-brings-reflexion-closer-to-expanding-cancer-treatment-market2026-06-12T15:38:27Z https://sofinnovapartners.com/news/biotalys-announces-second-closing-of-e45-million-series-c-financing-round2026-06-12T15:38:27Z https://sofinnovapartners.com/news/bommy-lee-joins-sofinnova-partners-as-head-of-communications2026-06-12T15:38:27Z https://sofinnovapartners.com/news/sofinnova-partners-three-new-investments2026-09-04T08:38:35Z https://sofinnovapartners.com/news/biotalys-collaboration-chrysal-evaluate-potential-biofungicide-flowers2026-09-04T08:38:35Z https://sofinnovapartners.com/news/sofinnova-partners-promotion-michael-krel-partner-industrial2026-09-04T08:38:35Z https://sofinnovapartners.com/news/hookipas-gilead-sciences-collaboration-hiv-hbv-therapeutic-vaccines2026-09-04T08:38:35Z https://sofinnovapartners.com/news/medday-reports-last-patient-study-visit-phase-3-clinical-trial-md10032026-09-04T08:38:35Z https://sofinnovapartners.com/news/inotrem-enrollment-first-patient-phase-iib-astonish-trial-nangibotide2026-09-04T08:38:35Z https://sofinnovapartners.com/news/tissium-closes-e39m-series-b-funding-round2026-06-12T15:38:27Z https://sofinnovapartners.com/news/avantium-nominates-edwin-moses-as-chairman-of-its-supervisory-board2026-06-12T15:38:27Z https://sofinnovapartners.com/news/sofinnova-partners-raises-e333-million-capital-ix-early-stage-healthcare-fund2026-06-12T15:38:27Z https://sofinnovapartners.com/news/proqr-prices-50-million-underwritten-public-offering-of-ordinary-shares2026-06-12T15:38:27Z https://sofinnovapartners.com/news/iomx-therapeutics-executive-management-team-supervisory-board-apollon2026-09-04T08:38:35Z https://sofinnovapartners.com/news/mnemo-therapeutics-75-million-series2026-09-04T08:38:35Z https://sofinnovapartners.com/news/micropep-technologies-appoints-dr-mikael-courbot-chief-technical-officer2026-09-04T08:38:35Z https://sofinnovapartners.com/news/inotrem-e39-million-series-b-financing-develop-first-class-immunology2026-09-04T08:38:35Z https://sofinnovapartners.com/news/hotspot-therapeutics-announces-acquisition-of-macroceutics-inc2026-06-12T15:38:27Z https://sofinnovapartners.com/news/agrosavfe-raises-e35-million-in-series-c-financing2026-06-12T14:16:14Z https://sofinnovapartners.com/news/sofinnova-partners-announces-the-sale-of-breath-therapeutics-to-zambon2026-06-12T15:38:27Z https://sofinnovapartners.com/news/agrosavfe-appoints-patrice-selles-new-chief-executive-officer2026-09-04T08:38:35Z https://sofinnovapartners.com/news/labiotech-eu-business-biotech-what-do-when-st-hits-fan-antoine2026-09-04T08:38:35Z https://sofinnovapartners.com/news/comet-bio-completes-equity-financing-and-opens-u-s-headquarters-in-chicagoland-area2026-06-12T15:38:27Z https://sofinnovapartners.com/news/abivax-completes-e12-million-capital-raise-entirely-subscribed2026-09-04T08:38:35Z https://sofinnovapartners.com/news/ablacare-series-a-financing-10-million-sofinnova-partners-infertility2026-09-04T08:38:35Z https://sofinnovapartners.com/news/enginzyme-awarded-as-technology-pioneer-2021-by-world-economic-forum2026-06-12T15:38:30Z https://sofinnovapartners.com/news/dmc-biotechnologies-inc-first-close-10-3m-series-a-financing-led2026-09-04T08:38:35Z https://sofinnovapartners.com/news/comet-therapeutics-raises-28-5-million-series-a-financing-support2026-09-04T08:38:35Z https://sofinnovapartners.com/news/sofinnova-partners-dna-script-raises-38-5-million-in-series-b-financing2026-06-12T15:38:30Z https://sofinnovapartners.com/news/cincor-pharma-licenses-aldosterone-synthase-inhibitor-cin-1072026-09-04T08:38:35Z https://sofinnovapartners.com/news/sofinnova-partners-invests-in-twentyeight-seven-therapeutics-22026-05-25T10:28:10Z https://sofinnovapartners.com/news/hookipa-pharma-announces-pricing-of-initial-public-offering2026-06-12T15:38:30Z https://sofinnovapartners.com/news/nodthera-progress-advancement-lead-development-candidate2026-09-04T08:38:35Z https://sofinnovapartners.com/news/safeheal-obtains-ce-mark-for-colovac-its-novel-endoluminal-bypass-sheath2026-06-12T15:38:30Z https://sofinnovapartners.com/news/afyren-spi-industrial-projects-fund-operated-bpifrance-creation2026-09-04T08:38:35Z https://sofinnovapartners.com/news/medtech-accelerator-sofinnova-md-start-iii-launches-call-early-stage2026-09-04T08:38:35Z https://sofinnovapartners.com/news/shockwave-closing-initial-public-offering-full-exercise-underwriters2026-09-04T08:38:35Z https://sofinnovapartners.com/news/dna-script-worlds-first-enzymatic-synthesis-high-purity-200-nucleotide2026-09-04T08:38:35Z https://sofinnovapartners.com/news/micropep-technologies-establishes-first-board-directors2026-09-04T08:38:35Z https://sofinnovapartners.com/news/sofinnova-partners-antoine-papiernik-invivo-magazine-interview2026-09-04T08:38:35Z https://sofinnovapartners.com/news/hookipa-pharma-raises-37-4-million-e33-2-million-in-series-d-financing2026-06-12T15:38:30Z https://sofinnovapartners.com/news/sofinnova-managing-partner-chairman-antoine-papiernik-on-cnbc2026-09-04T08:38:35Z https://sofinnovapartners.com/news/hookipa-appoints-michael-a-kelly-as-independent-director2026-06-12T15:38:30Z https://sofinnovapartners.com/news/afyren-secures-over-60-million-euros-financing-move-into-industrial2026-09-04T08:38:35Z https://sofinnovapartners.com/news/inotrem-extension-license-agreement-biomarker-soluble-trem-12026-09-04T08:38:35Z https://sofinnovapartners.com/news/avantium-takes-full-ownership-of-synvina2026-06-12T15:38:33Z https://sofinnovapartners.com/news/gensight-biologics-nature-medicine-case-report-visual-recovery-after2026-09-04T08:38:35Z https://sofinnovapartners.com/news/highlife-closes-a-e32-million-round-b-financing2026-06-12T15:38:33Z https://sofinnovapartners.com/news/asceneuron-appoints-peter-van-vlasselaer-as-chairman2026-06-12T15:38:33Z https://sofinnovapartners.com/news/pixium-vision-wireless-prima-chip-met-interim-study-endpoints-dry-age2026-09-04T08:38:35Z https://sofinnovapartners.com/news/hookipa-achieves-first-research-milestone-hiv-collaboration-license2026-09-04T08:38:35Z https://sofinnovapartners.com/news/proqr-publication-nature-medicine-qr-110-data-lebers-congenital2026-09-04T08:38:35Z https://sofinnovapartners.com/news/shockwave-announces-collaboration-with-abiomed-on-physician-training2026-06-12T15:38:33Z https://sofinnovapartners.com/news/pixium-vision-awarded-galien-prize-2018-for-research-with-prima-system-for-dry-amd2026-06-12T15:38:33Z https://sofinnovapartners.com/news/computer-aided-biology-pioneer-synthace-secures-25-6-million-in-series-b-funding2026-06-12T15:38:33Z https://sofinnovapartners.com/news/hookipa-appoints-julie-oneill-as-a-non-executive-director2026-06-12T15:38:33Z https://sofinnovapartners.com/news/erydel-appoints-stan-musial-as-chief-financial-officer2026-06-12T15:38:33Z https://sofinnovapartners.com/news/abivax-reports-excellent-efficacy-safety-abx464-phase-2b-trial2026-09-04T08:38:35Z https://sofinnovapartners.com/news/erydel-appoints-ronan-w-gannon-as-chief-commercial-officer2026-06-12T15:38:33Z https://sofinnovapartners.com/news/new-biopharmaceutical-company-sitryx-launches-30-million-fundraising2026-09-04T08:38:35Z https://sofinnovapartners.com/news/synthace-launches-ground-breaking-new-whitepaper2026-09-04T08:38:35Z https://sofinnovapartners.com/news/dna-script-worlds-first-enzymatic-synthesis-high-purity-150-nucleotide2026-09-04T08:38:35Z https://sofinnovapartners.com/news/inotrem-positive-results-phase-iia-study-lead-compound-nangibotide2026-09-04T08:38:35Z https://sofinnovapartners.com/news/proqr-closing-underwritten-public-offering-ordinary-shares-full2026-09-04T08:38:35Z https://sofinnovapartners.com/news/hotspot-therapeutics-completes-45-million-series-a-financing-advance2026-09-04T08:38:35Z https://sofinnovapartners.com/news/breath-therapeutics-appoints-noreen-roth-henig-m-d-as-chief-medical-officer2026-06-12T15:38:33Z https://sofinnovapartners.com/news/le-programme-calypso-va-beneficier-dune-aide-14-millions-deuros-dans2026-09-04T08:38:35Z https://sofinnovapartners.com/news/corwaves-next-generation-lvad-neptune-receives-funding2026-06-12T15:38:33Z https://sofinnovapartners.com/news/avantium-reaches-key-commercial-milestone-fdca-flagship-plant2026-09-04T08:38:35Z https://sofinnovapartners.com/news/sofinnova-partners-announces-the-sale-of-recor-medical-to-otsuka-holdings2026-06-12T15:38:35Z https://sofinnovapartners.com/news/renewable-chemicals-naturally-designed-engineered-deliver-performance2026-09-04T08:38:35Z https://sofinnovapartners.com/news/nodthera-secures-28-million-40-million-series-a-financing2026-06-12T15:38:35Z https://sofinnovapartners.com/news/hookipa-gilead-enter-into-collaboration-license-agreement2026-09-04T08:38:38Z https://sofinnovapartners.com/news/zai-lab-crescendo-biologics-enter-exclusive-worldwide-license2026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-appoints-dr-martin-t-rothman-as-venture-partner2026-06-12T15:38:35Z https://sofinnovapartners.com/news/highlife-appoints-dr-martin-rothman-as-independent-mamber-of-the-board2026-06-12T15:38:35Z https://sofinnovapartners.com/news/shockwave-launches-coronary-intravascular-lithotripsy-in-europe2026-06-12T15:38:35Z https://sofinnovapartners.com/news/corvidia-therapeutics-secures-60-million-series-b-funding-accelerate2026-09-04T08:38:38Z https://sofinnovapartners.com/news/synthace-appoints-bob-wiederhold-as-chairman-of-its-board-of-directors2026-06-12T15:38:35Z https://sofinnovapartners.com/news/protera-appoints-novozymes-executive-thomas-videbaek-chair-board2026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-leads-erydels-e26-5-million-financing2026-06-12T15:38:35Z https://sofinnovapartners.com/news/armance-bordes-joins-sofinnova-partners-as-general-counsel2026-06-12T15:38:35Z https://sofinnovapartners.com/news/sofinnova-partners-leads-inventiva-pharma-e355-m-capital-increase2026-06-12T15:38:35Z https://sofinnovapartners.com/news/limflow-annonce-une-levee-fonds-serie-c-27-millions-deuros-mene-par2026-09-04T08:38:38Z https://sofinnovapartners.com/news/biotechnologies-enobraq-monte-en-puissance2026-06-12T15:38:35Z https://sofinnovapartners.com/news/enobraq-is-gaining-momentum2026-06-12T15:38:35Z https://sofinnovapartners.com/news/reflexion-medical-raises-100-million-series-c-commercialize-cancer2026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-launches-healthcare-crossover-fund-with-e275-million-340-million2026-06-12T15:38:35Z https://sofinnovapartners.com/news/sofinnova-partners-leads-safeheals-e6-million-series-a-financing-round2026-05-28T09:03:32Z https://sofinnovapartners.com/news/sofinnova-partners-mene-le-tour-financement-serie-6-millions-deuros-la2026-09-04T08:38:38Z https://sofinnovapartners.com/news/proqr-positive-results-clinical-trial-qr-421a-usher-syndrome-plans2026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-mene-le-tour-financement-serie-4-me-la-societe2026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-leads-micropep-technologies-e4m-series-a-financing-round2026-06-12T15:38:35Z https://sofinnovapartners.com/news/gecko-biomedical-secures-e6-million-funding-under-investments-future2026-09-04T08:38:38Z https://sofinnovapartners.com/news/gecko-biomedical-obtient-6-millions-deuros-financement2026-09-04T08:38:38Z https://sofinnovapartners.com/news/pixium-vision-receives-fda-approval-begin-human-clinical-study-prima2026-09-04T08:38:38Z https://sofinnovapartners.com/news/ecolab-agrees-to-acquire-minority-ownership-in-finnish-metgen-oy2026-06-12T15:38:38Z https://sofinnovapartners.com/news/mainstay-medical-announces-positive-outcome-of-interim-analysis2026-06-12T15:38:38Z https://sofinnovapartners.com/news/hookipa-biotech-raises-60-million-e50-million-in-an-oversubscribed-round-c-financing2026-06-12T15:38:38Z https://sofinnovapartners.com/news/highlife-appoints-jose-calle-gordo-as-chairman-of-the-board2026-06-12T15:38:38Z https://sofinnovapartners.com/news/avantium-secures-new-offtake-contracts-for-planned-fdca-flagship-plant2026-06-12T15:38:38Z https://sofinnovapartners.com/news/proqr-receives-orphan-drug-designation-ema-drug-candidate-qr-3132026-09-04T08:38:38Z https://sofinnovapartners.com/news/maina-bhaman-joins-sofinnova-partners-as-partner2026-06-12T15:38:38Z https://sofinnovapartners.com/news/maina-bhaman-rejoint-sofinnova-partners-en-tant-que-partner2026-06-12T15:38:38Z https://sofinnovapartners.com/news/inotrem-granted-access-priority-medicines-scheme-prime-lead-compound2026-09-04T08:38:38Z https://sofinnovapartners.com/news/inotrem-obtient-le-statut-medicament-prioritaire-prime-pour-sa2026-09-04T08:38:38Z https://sofinnovapartners.com/news/proqr-doses-first-lca-10-patient-clinical-trial-qr-110-proqrs-lead2026-09-04T08:38:38Z https://sofinnovapartners.com/news/inotrem-et-roche-diagnostics-signent-un-accord-collaborationa2026-09-04T08:38:38Z https://sofinnovapartners.com/news/inotrem-roche-diagnostics-sign-rd-collaboration-agreement2026-09-04T08:38:38Z https://sofinnovapartners.com/news/highlife-leve-12-3me-lors-dun-tour-de-financement-mene-par-sofinnova-partners2026-06-12T14:16:15Z https://sofinnovapartners.com/news/highlife-closes-e12-3-million-financing-round-led-by-sofinnova-partners2026-06-12T15:38:38Z https://sofinnovapartners.com/news/inotrem-bolsters-leadership-team-with-the-appointment-of-sven-zimmermann-as-new-ceo2026-06-12T15:38:38Z https://sofinnovapartners.com/news/avantium-nominates-kees-verhaar-as-chairman-supervisory-board2026-05-25T10:01:57Z https://sofinnovapartners.com/news/pixium-vision-receives-approval-first-human-clinical-trial2026-09-04T08:38:38Z https://sofinnovapartners.com/news/dr-jan-van-de-winkel-joins-hookipa-as-chairman-of-its-board-of-directors2026-06-12T15:38:38Z https://sofinnovapartners.com/news/shockwave-medical-announces-35-million-in-new-financing2026-06-12T15:38:38Z https://sofinnovapartners.com/news/la-releve-les-echos2026-06-12T15:38:40Z https://sofinnovapartners.com/news/noxxon-publie-des-donnees-precliniques-preuve-concept-relatives2026-09-04T08:38:38Z https://sofinnovapartners.com/news/nucana-plc-announces-pricing-of-initial-public-offering2026-06-12T15:38:40Z https://sofinnovapartners.com/news/noxxon-provides-update-ongoing-phase-12-clinical-trial-with-lead-program-nox-a122026-06-12T15:38:40Z https://sofinnovapartners.com/news/p10217-15869589902632026-06-12T15:38:40Z https://sofinnovapartners.com/news/moon-surgical-kings-college-london-strategic-partnership2026-09-04T08:38:38Z https://sofinnovapartners.com/news/henrijette-richter-est-promue-managing-partner-de-sofinnova-partners2026-06-12T15:38:40Z https://sofinnovapartners.com/news/p102112026-06-12T14:16:16Z https://sofinnovapartners.com/news/synthace-raises-7-3m-to-accelerate-biotechnology-to-enable-faster-breakthroughs2026-06-12T15:38:40Z https://sofinnovapartners.com/news/proqr-receives-orphan-drug-designation-fda-drug-candidate-qr-3132026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-dna-script-series-a-fundraising-e11-m-advance2026-09-04T08:38:38Z https://sofinnovapartners.com/news/proqr-rd-day-progress-pipeline-introduces-axiomer-novel-proprietary2026-09-04T08:38:38Z https://sofinnovapartners.com/news/calliditas-submission-new-drug-application-u-fda-nefecon-patients2026-09-04T08:38:38Z https://sofinnovapartners.com/news/avantium-announces-bbi-subsidy-eur-25-million2026-09-04T08:38:38Z https://sofinnovapartners.com/news/proqr-present-qr-010-data-european-cystic-fibrosis-society-conference2026-09-04T08:38:38Z https://sofinnovapartners.com/news/proqr-receives-fast-track-designation-fda-qr-110-lebers-congenital2026-09-04T08:38:38Z https://sofinnovapartners.com/news/graziano-seghezzi-est-promu-managing-partner-de-sofinnova-partners2026-06-12T14:16:15Z https://sofinnovapartners.com/news/graziano-seghezzi-appointed-managing-partner-of-sofinnova-partners2026-06-12T15:38:43Z https://sofinnovapartners.com/news/proqr-announces-results-for-the-first-quarter-of-20172026-06-12T15:38:43Z https://sofinnovapartners.com/news/noxxon-pharma-collaboration-national-center-tumor-diseases-heidelberg2026-09-04T08:38:38Z https://sofinnovapartners.com/news/abivax-publishes-data-abx464-induction-long-term-maintenance-phase-2a2026-09-04T08:38:38Z https://sofinnovapartners.com/news/shockwave-medical-appoints-doug-godshall-as-president-and-ceo2026-06-12T15:38:43Z https://sofinnovapartners.com/news/mainstay-medical-starts-commercialization-reactiv8-treatment2026-09-04T08:38:38Z https://sofinnovapartners.com/news/reflexion-medical-appoints-industry-veteran-todd-powell-president-and-ceo2026-05-26T10:08:14Z https://sofinnovapartners.com/news/hookipa-biotech-presents-positive-data-phase-1-first-human-trial2026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-closes-445m-540m-oversubscribed-late-stage2026-09-04T08:38:38Z https://sofinnovapartners.com/news/mission-therapeutics-university-oxford-awarded-research-grant-michael2026-09-04T08:38:38Z https://sofinnovapartners.com/news/crescendo-biologics-appoints-philip-bland-ward-as-chief-scientific-officer2026-06-12T15:38:43Z https://sofinnovapartners.com/news/antoine-papiernik-appointed-chairman-of-sofinnova-partners2026-06-12T15:38:43Z https://sofinnovapartners.com/news/proqr-appoints-david-m-rodman-md-as-chief-development-strategy-officer2026-06-12T15:38:43Z https://sofinnovapartners.com/news/sofinnova-partners-ipo-avantium-front-runner-renewable-chemistry2026-09-04T08:38:38Z https://sofinnovapartners.com/news/obseva-starts-phase-3-clinical-program-for-nolasiban-in-art2026-06-12T15:38:45Z https://sofinnovapartners.com/news/breath-therapeutics-raises-eur-43-5-million-in-series-a-financing2026-06-12T15:38:45Z https://sofinnovapartners.com/news/sofinnova-partners-invests-in-agrosavfe2026-06-12T15:38:45Z https://sofinnovapartners.com/news/mainstay-medical-announces-us108-million-equity-financing-transaction2026-06-12T15:38:45Z https://sofinnovapartners.com/news/dr-igor-matushansky-appointed-global-head-research-and-development-of-hookipa-biotech2026-06-12T15:38:45Z https://sofinnovapartners.com/news/sofinnova-partners-raises-e106-million-first-closing-industrial2026-09-04T08:38:38Z https://sofinnovapartners.com/news/comet-biorefining-completes-equity-financing2026-06-12T15:38:45Z https://sofinnovapartners.com/news/lysogene-receives-orphan-drug-designation-ema-lys-gm101-treatment-gm12026-09-04T08:38:38Z https://sofinnovapartners.com/news/michael-clayman-ceo-flexion-therapeutics-underscores-need-new-osteoarthritis-treatment2026-09-04T08:38:38Z https://sofinnovapartners.com/news/bioamber-ceo-steps-down-current-coo-fabrice-orecchioni-named-president2026-06-12T15:38:45Z https://sofinnovapartners.com/news/pixium-vision-receives-nub-innovation-reimbursement-status-1-1502026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-congratulates-portfolio-company-dna-script-success2026-09-04T08:38:38Z https://sofinnovapartners.com/news/enginzyme-extends-series-11-million-advance-cell-free-chemical2026-09-04T08:38:38Z https://sofinnovapartners.com/news/lysogene-announces-its-successful-ipo-on-euronext-paris-with-nearly-e22-6-m-raised2026-06-12T15:38:45Z https://sofinnovapartners.com/news/mainstay-medical-starts-commercialization-reactiv8-treatment-chronic2026-09-04T08:38:38Z https://sofinnovapartners.com/news/sofinnova-partners-announces-the-acquisition-of-delinia-by-celgene-corporation2026-06-12T15:38:47Z https://sofinnovapartners.com/news/obseva-sa-announces-pricing-of-initial-public-offering2026-06-12T15:38:47Z https://sofinnovapartners.com/news/dna-script-adds-dr-heiner-dreismann-former-ceo-roche-molecular2026-09-04T08:38:38Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-extends-series-a-financing-raising-a-total-of-35m2026-06-12T15:38:47Z https://sofinnovapartners.com/news/cerenis-clinical-progress-cash-position-and-revenue-for-q4-20162026-06-12T15:38:47Z https://sofinnovapartners.com/news/obseva-expands-leadership-team-and-board-of-directors-with-industry-veterans2026-06-12T15:38:47Z https://sofinnovapartners.com/news/stentys-2016-annual-revenues-up-20-at-e7-3-million2026-06-12T15:38:47Z https://sofinnovapartners.com/news/pixium-vision-realise-limplantation-10-patients-avec-iris-ii-son2026-09-04T08:38:38Z https://sofinnovapartners.com/news/dna-script-to-present-at-the-biotech-showcase-conference-in-san-francisco2026-06-12T15:38:47Z https://sofinnovapartners.com/news/corwave-start-up-co-bfm-040120172026-06-12T15:38:47Z https://sofinnovapartners.com/news/biotalys-submits-first-protein-based-biocontrol-registration-package-to-the-epa2026-06-12T15:38:47Z https://sofinnovapartners.com/news/lysogene-appoints-david-schilansky-to-board-of-directors2026-06-12T15:38:50Z https://sofinnovapartners.com/news/asceneuron-appoints-j-michael-ryan-m-d-as-chief-medical-officer2026-06-12T15:38:50Z https://sofinnovapartners.com/news/shockwave-medical-raises-45-million-series-c-financing2026-09-04T08:38:38Z https://sofinnovapartners.com/news/proqr-announces-results-for-the-third-quarter-of-20162026-06-12T15:38:50Z https://sofinnovapartners.com/news/moon-surgical-formerly-mastor-appointment-experienced-core-team2026-09-04T08:38:38Z https://sofinnovapartners.com/news/corwave-raises-17-1-million-in-series-b-financing2026-06-12T15:38:50Z https://sofinnovapartners.com/news/obseva-results-implant-phase-2-trial-obe001-nolasiban-improvement2026-09-04T08:38:38Z https://sofinnovapartners.com/news/crescendo-biologics-takeda-enter-collaboration-humabody-based2026-09-04T08:38:38Z https://sofinnovapartners.com/news/asceneuron-receives-grant-from-the-michael-j-fox-foundation-for-parkinsons-research2026-06-12T15:38:50Z https://sofinnovapartners.com/news/iomx-therapeutics-raises-eur-40-million-in-series-a-round2026-06-12T15:38:50Z https://sofinnovapartners.com/news/corwave-raises-35-million-series-c-funding-breakthrough-heart-pump2026-09-04T08:38:38Z https://sofinnovapartners.com/news/delinia-35-million-series-a-financing-advance-novel-therapeutics2026-09-04T08:38:38Z https://sofinnovapartners.com/news/rgenix-33-million-series-b-financing-develop-first-class-cancer2026-09-04T08:38:41Z https://sofinnovapartners.com/news/jorn-aldag-appointed-ceo-of-hookipa-biotech2026-06-12T15:38:52Z https://sofinnovapartners.com/news/pixium-vision-receives-clinical-trial-approval-uk-regulatory-authority2026-09-04T08:38:41Z https://sofinnovapartners.com/news/mainstay-medical-achieves-ce-marking-reactiv8-prepares-commercial2026-09-04T08:38:41Z https://sofinnovapartners.com/news/peijia-medical-highlife-enter-into-license-technology-transfer2026-09-04T08:38:41Z https://sofinnovapartners.com/news/recor-medical-collaboration-investment-otsuka-holdings2026-09-04T08:38:41Z https://sofinnovapartners.com/news/shockwave-medical-positive-study-results-novel-lithoplasty-system2026-09-04T08:38:41Z https://sofinnovapartners.com/news/proqr-investor-analyst-event-pre-clinical-data-presentations-qr-1102026-09-04T08:38:41Z https://sofinnovapartners.com/news/medday-reports-full-data-pivotal-phase-studies2026-09-04T08:38:41Z https://sofinnovapartners.com/news/avantium-raises-e20m-in-a-financing-round-led-by-pmv2026-06-12T15:38:52Z https://sofinnovapartners.com/news/3-new-funds-join-sofinnova-partners-in-enobraq-through-a-2-9-me-financing2026-06-12T15:38:52Z https://sofinnovapartners.com/news/reflexion-medical-raises-46-million-series-b-financing-led-by-kck-group2026-06-12T15:38:52Z https://sofinnovapartners.com/news/medday-secures-e34-million-38-5m-new-funding2026-06-12T15:38:52Z https://sofinnovapartners.com/news/corvent-medical-strategic-partnership-siemens-healthineers2026-09-04T08:38:41Z https://sofinnovapartners.com/news/recor-medical-initial-enrollments-radiance-htn-hypertension-clinical2026-09-04T08:38:41Z https://sofinnovapartners.com/news/flexion-therapeutics-presentation-results-pivotal-phase-2b-phase-32026-09-04T08:38:41Z https://sofinnovapartners.com/news/gecko-biomedical-raises-e22-5-million-led-by-sofinnova-partners2026-06-12T15:38:55Z https://sofinnovapartners.com/news/basf-and-avantium-intend-to-establish-joint-venture2026-06-12T15:38:55Z https://sofinnovapartners.com/news/cellucomp-completes-3-7-million-financing2026-06-12T15:38:55Z https://sofinnovapartners.com/news/world-premiere-pixium-vision-implants-iris-ii-first-epi-retinal2026-09-04T08:38:41Z https://sofinnovapartners.com/news/recor-medical-announces-ide-approval-for-radiance-htn-hypertension-clinical-trial2026-06-12T15:38:55Z https://sofinnovapartners.com/news/sonova-invests-5-million-sensorion-companies-plan-collaboration2026-09-04T08:38:41Z https://sofinnovapartners.com/news/corvidia-therapeutics-raises-26m-series-a-financing-led-sofinnova2026-09-04T08:38:41Z https://sofinnovapartners.com/news/comet-biorefining-to-build-first-commercial-biomass-sugar-plant-in-sarnia-ontario2026-06-12T15:38:55Z https://sofinnovapartners.com/news/sofinnova-partners-leads-enyo-pharma-e22m-financing2026-06-12T15:38:55Z https://sofinnovapartners.com/news/mission-therapeutics-raises-60-million-to-progress2026-06-12T15:38:55Z https://sofinnovapartners.com/news/bioamber-inc-announces-pricing-of-13-0-million-public-offering2026-06-12T15:38:55Z https://sofinnovapartners.com/news/sofinnova-partners-raises-e300-million-healthcare-fund2026-06-12T15:38:57Z https://sofinnovapartners.com/news/gensight-biologics-publication-results-lumevoq-reverse-pivotal-phase2026-09-04T08:38:41Z https://sofinnovapartners.com/news/additional-data-confirm-positive-results-for-clinical-trial-of-reactiv82026-06-12T15:38:57Z https://sofinnovapartners.com/news/twb-creation-enobraq-specialist-co2-capture-exploitation-using-yeast-22026-09-04T08:38:41Z https://sofinnovapartners.com/news/lysogene-receives-orphan-drug-designation-rare-pediatric-disease2026-09-04T08:38:41Z https://sofinnovapartners.com/news/obseva-closes-chf-60-usd-60-million-in-series-b-financing2026-06-12T15:38:57Z https://sofinnovapartners.com/news/crescendo-biologics-appoints-dr-kevin-johnson-as-chairman2026-06-12T15:38:57Z https://sofinnovapartners.com/news/sofinnova-launches-biovelocita-the-first-biotech-accelerator-in-italy2026-06-12T15:38:57Z https://sofinnovapartners.com/news/twb-creation-enobraq-specialist-co2-capture-exploitation-using-yeast2026-09-04T08:38:41Z https://sofinnovapartners.com/news/mainstay-medical-applies-for-ce-mark-for-reactiv8-22026-06-12T15:38:57Z https://sofinnovapartners.com/news/mainstay-medical-applies-for-ce-mark-for-reactiv82026-06-12T15:38:57Z https://sofinnovapartners.com/news/green-chemistry-industrial-scale-afyren-starts-construction-first2026-09-04T08:38:41Z https://sofinnovapartners.com/news/reflexion-medical-achieves-major-milestones-development-biologically2026-09-04T08:38:41Z https://sofinnovapartners.com/news/dow-agrosciences-synthace-research-collaboration-accelerate-product2026-09-04T08:38:41Z https://sofinnovapartners.com/news/asceneuron-raises-chf-30-million-series-a-financing-round-led2026-09-04T08:38:41Z https://sofinnovapartners.com/news/obseva-appoints-elke-bestel-chief-medical-officer-jean-pierre2026-09-04T08:38:41Z https://sofinnovapartners.com/news/positive-results-for-mainstay-medicals-clinical-trial-of-reactiv82026-05-25T10:24:55Z https://sofinnovapartners.com/news/bio-world-congress-on-industrial-biotechnology2026-06-12T15:39:00Z https://sofinnovapartners.com/news/mozart-therapeutics-launches-55-million-series-a-financing-develop2026-09-04T08:38:41Z https://sofinnovapartners.com/news/corvent-medical-receives-fda-emergency-use-authorization-novel-respond2026-09-04T08:38:41Z https://sofinnovapartners.com/news/nucanas-appoints-professor-chris-mcguigan-as-chief-scientific-officer2026-09-04T08:38:41Z https://sofinnovapartners.com/news/mission-therapeutics-appoints-dr-colin-goddard-to-its-board-of-directors2026-06-12T15:39:00Z https://sofinnovapartners.com/news/nucana-appoints-martin-j-birkhofer-m-d-as-chief-medical-officer2026-06-12T15:39:00Z https://sofinnovapartners.com/news/mainstay-medical-strengthens-board-with-new-independent-director2026-06-12T15:39:00Z https://sofinnovapartners.com/news/creabilis-appoints-catherine-moukheibir-as-chairman-of-its-board-of-directors2026-06-12T15:39:00Z https://sofinnovapartners.com/news/hookipa-pharmas-lcmv-based-immunotherapy-hpv16-cancers-high2026-09-04T08:38:41Z https://sofinnovapartners.com/news/mainstay-medical-gains-approval-to-start-us-clinical-trial-of-reactiv82026-06-12T15:39:00Z https://sofinnovapartners.com/news/shockwave-medical-40-million-funding-novel-lithoplasty-system-treat2026-09-04T08:38:41Z https://sofinnovapartners.com/news/stentys-next-generation-self-apposing-stent-system-receives-ce-marking2026-09-04T08:38:41Z https://sofinnovapartners.com/news/pixium-vision-publication-prima-results-wireless-subretinal-implant2026-09-04T08:38:41Z https://sofinnovapartners.com/news/medday-reports-positive-pivotal-phase-iii-study-results-md10032026-09-04T08:38:41Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-appoints-kazumi-shiosaki-board-directors-lisa2026-09-04T08:38:41Z https://sofinnovapartners.com/news/medday-pivotal-phase-iii-study-md1003-patients-progressive-multiple2026-09-04T08:38:41Z https://sofinnovapartners.com/news/lysogene-appoints-annette-clancy-as-chair-of-the-board2026-06-12T15:39:02Z https://sofinnovapartners.com/news/cellucomp-plant-opened-by-annabelle-ewing-msp2026-06-12T15:39:02Z https://sofinnovapartners.com/news/redx-pharma-plc-placing-raise-c-25-5-million-open-offer-raise-up-2-22026-09-04T08:38:41Z https://sofinnovapartners.com/news/proqr-therapeutics-announces-results-for-the-fourth-quarter-and-full-year-20142026-06-12T15:39:05Z https://sofinnovapartners.com/news/lysogene-university-massachusetts-medical-school-auburn-unniversity2026-09-04T08:38:41Z https://sofinnovapartners.com/news/comet-biorefining-secures-funding-led-by-sofinnova-partners-22026-06-12T15:39:05Z https://sofinnovapartners.com/news/sofinnova-partners-portfolio-company-glycovaxyn-sold-glaxosmithkline2026-09-04T08:38:41Z https://sofinnovapartners.com/news/ascendis-pharma-closing-initial-public-offering-including-full2026-09-04T08:38:41Z https://sofinnovapartners.com/news/ascendis-pharma-closing-initial-public-offering2026-09-04T08:38:41Z https://sofinnovapartners.com/news/noema-pharma-raises-chf54-million-series-a-financing2026-09-04T08:38:41Z https://sofinnovapartners.com/news/promising-phase-i-interim-data-expec-vaccine-program-triggers-payment2026-09-04T08:38:41Z https://sofinnovapartners.com/news/promising-phase-i-interim-data-expec-vaccine-program2026-09-04T08:38:41Z https://sofinnovapartners.com/news/ascendis-pharma-initiation-phase-1-single-ascending-dose-study-22026-09-04T08:38:41Z https://sofinnovapartners.com/news/ascendis-pharma-initiation-phase-1-single-ascending-dose-study2026-09-04T08:38:41Z https://sofinnovapartners.com/news/mission-appoints-anker-lundemose-as-chief-executive-officer2026-06-12T15:39:05Z https://sofinnovapartners.com/news/shockwave-medical-ce-mark-approval-lithoplasty-system-treatment2026-09-04T08:38:41Z https://sofinnovapartners.com/news/home-biosciences-closes-usd15-million-seed-financing-led-redmile-group2026-09-04T08:38:41Z https://sofinnovapartners.com/news/synthace-raises-usd35m-expand-access-r-d-technology2026-09-04T08:38:41Z https://sofinnovapartners.com/news/sofinnova-partners-raises-eur150m-third-industrial-biotech-fund2026-09-04T08:38:41Z https://sofinnovapartners.com/news/catamaran-bio-launches-42-million-financing-develop-off-shelf-car-nk2026-09-04T08:38:41Z https://sofinnovapartners.com/news/epsilen-bio-acquisition-chroma-medicine-forming-transatlantic-pioneer2026-09-04T08:38:41Z https://sofinnovapartners.com/news/dmc-announces-first-close-of-series-b-financing-raising-usd34-million2026-06-12T15:39:07Z https://sofinnovapartners.com/news/meiogenix-announces-usd13-million-series-a-financing-round-led-by-sofinnova-partners2026-06-12T15:39:07Z https://sofinnovapartners.com/news/sofinnova-partners-announces-a-new-investment-from-its-medtech-acceleration-fund2026-06-12T15:39:07Z https://sofinnovapartners.com/news/pixium-vision-receives-french-regulatory-authority-ansm-approval2026-09-04T08:38:41Z https://sofinnovapartners.com/news/michelin-pyrowave-join-forces-industrialize-plastic-waste-recycling2026-09-04T08:38:44Z https://sofinnovapartners.com/news/tissium-receives-fda-investigational-device-exemption-for-vascular-sealant2026-06-12T15:39:07Z https://sofinnovapartners.com/news/myricx-pharma-launches-4-5m-financing-progress-novel-nmt-inhibitors2026-09-04T08:38:44Z https://sofinnovapartners.com/news/sofinnova-partners-raises-472-548-million-form-largest-early-stage2026-09-04T08:38:44Z https://sofinnovapartners.com/news/calliditas-announces-positive-topline-results-from-pivotal-phase-3-nefigard-trial2026-06-04T15:12:17Z https://sofinnovapartners.com/news/gensight-biologics-reports-validation-lumevoq-marketing-authorisation2026-09-04T08:38:44Z https://sofinnovapartners.com/news/inventiva-publication-scientific-paper-role-ppars-treatment-nash2026-09-04T08:38:44Z https://sofinnovapartners.com/news/redx-pharma-names-dr-jane-robertson-as-chief-medical-officer2026-09-04T08:38:44Z https://sofinnovapartners.com/news/gensight-biologics-raises-25-million-oversubscribed-private-placement2026-09-04T08:38:44Z https://sofinnovapartners.com/news/cincor-pharma-announcses-first-patient-dosed-cin-107-phase-2-study2026-09-04T08:38:44Z https://sofinnovapartners.com/news/dr-joe-anderson-joins-sofinnova-partners2026-06-29T09:45:10Z https://sofinnovapartners.com/news/inventiva-receives-fda-breakthrough-therapy-designation-lead-drug2026-09-04T08:38:44Z https://sofinnovapartners.com/news/afyren-appoints-stefan-borgas-as-chairman-of-the-board2026-06-12T15:39:07Z https://sofinnovapartners.com/news/proqr-appoints-naveed-shams-md-phd-as-chief-scientific-officer2026-06-12T15:39:07Z https://sofinnovapartners.com/news/cincor-pharma-raises-143-million-in-series-b-financing2026-05-28T09:10:29Z https://sofinnovapartners.com/news/european-house-ambrosetti-sofinnova-partners-hosting-bioequity-europe2026-09-04T08:38:44Z https://sofinnovapartners.com/news/biotalys-awarded-eur1-6-million-vlaio-research-grant2026-05-28T09:01:27Z https://sofinnovapartners.com/news/reflexion-sofinnova-partners-recognized-salus-excellence-award2026-09-04T08:38:44Z https://sofinnovapartners.com/news/sensorion-raises-approximately-31-million2026-09-04T08:38:44Z https://sofinnovapartners.com/news/gradient-denervation-technologies-raises-3-5m-in-seed-funding-with-sofinnova-partners2026-06-29T09:45:10Z https://sofinnovapartners.com/news/biotalys-honored-with-two-agtech-breakthrough-awards2026-06-12T15:39:07Z https://sofinnovapartners.com/news/redx-new-research-collaboration-jazz-pharmaceuticals-discover-develop2026-09-04T08:38:44Z https://sofinnovapartners.com/news/calliditas-announces-agreement-to-acquire-controlling-interest-in-genkyotex-sa2026-06-12T15:39:10Z https://sofinnovapartners.com/news/appointment-of-non-executive-director-and-changes-to-board-committees2026-06-12T15:39:10Z https://sofinnovapartners.com/news/iomx-therapeutics-raises-eur-65-million-in-series-b-round2026-06-12T15:39:10Z https://sofinnovapartners.com/news/redx-signs-out-licensing-agreement-with-astrazeneca2026-06-12T15:39:10Z https://sofinnovapartners.com/news/corvent-medical-appoints-richard-s-walsh-as-chief-executive-officer2026-06-29T09:45:10Z https://sofinnovapartners.com/news/genespire-appoints-jorn-aldag-as-chairman-of-the-board-of-directors2026-06-29T09:45:10Z https://sofinnovapartners.com/news/dna-script-expands-series-b-to-89m2026-06-12T15:39:10Z https://sofinnovapartners.com/news/enthera-pharmaceuticals-raises-28-million-series-a-financing-advance2026-09-04T08:38:44Z https://sofinnovapartners.com/news/inotrem-receives-clearance-french-belgian-us-authorities-launch-phase2026-09-04T08:38:44Z https://sofinnovapartners.com/news/proqr-scientific-advisory-board-leaders-inherited-retinal-disease-rna2026-09-04T08:38:44Z https://sofinnovapartners.com/news/corwave-awarded-2-5m-from-the-european-commission-through-the-eic-accelerator-program2026-06-29T09:45:10Z https://sofinnovapartners.com/news/shockwave-appoints-maria-sainz-to-board-of-directors2026-06-12T15:39:10Z https://sofinnovapartners.com/news/verona-pharma-raises-200-million-in-oversubscribed-private-placement-and-subscription2026-06-12T15:39:10Z https://sofinnovapartners.com/news/afyren-lists-on-euronext-growth-paris2026-06-12T15:39:10Z https://sofinnovapartners.com/news/comet-bio-wins-start-up-of-the-year-nutraingredients-award-for-20202026-06-12T15:39:10Z https://sofinnovapartners.com/news/venus-medtech-partner-pi-cardia-bring-leaflex-aortic-valve-technology2026-09-04T08:38:44Z https://sofinnovapartners.com/news/inventiva-pricing-initial-public-offering-nasdaq-global-market2026-09-04T08:38:44Z https://sofinnovapartners.com/news/biotalys-appoints-wim-ottevaere-chief-financial-officer-preparation2026-09-04T08:38:44Z https://sofinnovapartners.com/news/reflexion-telix-pharmaceuticals-strategic-collaboration2026-09-04T08:38:44Z https://sofinnovapartners.com/news/prima-system-primavera-pivotal-study-success-7-3-million-raised2026-09-04T08:38:44Z https://sofinnovapartners.com/news/sensorion-appoints-dr-edwin-moses-former-ablynx-ceo-as-chairman-of-the-board2026-06-12T15:39:10Z https://sofinnovapartners.com/news/mastor-secures-seed-funding-sofinnova-partners-develop-laparoscopy2026-09-04T08:38:44Z https://sofinnovapartners.com/news/sofinnova-partners-two-first-investments-md-start-iii-medtech2026-09-04T08:38:44Z https://sofinnovapartners.com/news/redx-pharma-proposed-financing-30-million-via-issue-convertible-loan2026-09-04T08:38:44Z https://sofinnovapartners.com/news/tissium-raises-50m-in-series-c-financing-to-propel-its-platform-to-commercial-stage2026-06-12T15:39:13Z https://sofinnovapartners.com/news/elsan-partners-sofinnova-md-start-iii-acceleration-fund2026-09-04T08:38:44Z https://sofinnovapartners.com/news/mainstay-medical-wins-fda-approval-for-reactiv8-in-chronic-low-back-pain2026-06-29T08:21:50Z https://sofinnovapartners.com/news/shockwave-announces-pricing-of-public-offering-of-common-stock2026-06-12T15:39:13Z https://sofinnovapartners.com/news/inventivas-lanifibranor-meets-primary-key-secondary-endpoints-phase-twob2026-09-04T08:38:44Z https://sofinnovapartners.com/news/epsilen-bio-appoints-julia-berretta-chief-executive-officer-mathieu2026-09-04T08:38:44Z https://sofinnovapartners.com/news/synthace-tecan-collaboration-accelerate-purification-optimization2026-09-04T08:38:44Z https://sofinnovapartners.com/news/sofinnova-partners-announces-sale-of-corvidia-therapeutics-to-novo-nordisk2026-06-12T15:39:13Z https://sofinnovapartners.com/news/afyren-after-biochem-european-consortium-obtain-funding-20-million2026-09-04T08:38:44Z https://sofinnovapartners.com/news/protera-closes-5-6m-series-a-financing-led-by-sofinnova-partners2026-06-29T09:45:10Z https://sofinnovapartners.com/news/biotalys-expands-executive-team-establishes-u-headquarters-strengthen2026-09-04T08:38:44Z https://sofinnovapartners.com/about2026-06-08T12:04:10Z https://sofinnovapartners.com/news2026-07-15T10:42:21Z https://sofinnovapartners.com/portfolio2022-01-03T11:31:30Z https://sofinnovapartners.com/contact2022-03-04T08:52:18Z https://sofinnovapartners.com/strategy2026-07-21T15:15:09Z https://sofinnovapartners.com2026-07-21T15:11:41Z https://sofinnovapartners.com/esg2026-07-21T07:53:58Z https://sofinnovapartners.com/submit2022-03-04T08:52:37Z https://sofinnovapartners.com/team2024-08-30T14:00:06Z https://sofinnovapartners.com/news/why-is-fundraising-by-women-so-much-harder2026-06-12T15:39:13Z https://sofinnovapartners.com/portfolio/calliditas2026-01-29T09:02:59Z https://sofinnovapartners.com/portfolio/hotspot2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/tm3-therapeutics2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/safeheal2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/micropep2024-04-02T06:24:30Z https://sofinnovapartners.com/portfolio/biotalys2025-12-12T18:32:57Z https://sofinnovapartners.com/portfolio/dna-script2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/iomx2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/gecko-biomedical-22022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/comet-biorefining2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/shockwave-medical2024-08-07T12:41:13Z https://sofinnovapartners.com/portfolio/avantium2024-04-02T06:31:26Z https://sofinnovapartners.com/portfolio/hookipa-pharma2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/cerenis-therapeutics2024-04-02T06:31:41Z https://sofinnovapartners.com/portfolio/recor-medical2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/preglem2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/ethycal-oncologie-science2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/corevalve2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/genset-sa2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/protera2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/sitryx2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/quince-therapeutics-formerly-erydel2025-12-12T18:04:48Z https://sofinnovapartners.com/portfolio/nodthera2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/inventiva2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/highlife2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/enyo-pharma-32022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/asceneuron-22025-05-07T16:29:42Z https://sofinnovapartners.com/portfolio/reflexion-medical2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/inotrem2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/cellucomp2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/proqr-22022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/nucana-biomed2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/mission-therapeutics2024-07-25T11:03:39Z https://sofinnovapartners.com/portfolio/mainstay-medical2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/crescendo-biologics-22022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/noxxon-pharma-ag2024-04-02T06:29:40Z https://sofinnovapartners.com/portfolio/breath-therapeutics2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/delinia2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/glycovaxyn2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/omthera-pharmaceuticals2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/ascendis-pharma-as2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/movetis2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/dbv-technologies2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/addex-therapeutics2023-09-05T17:32:22Z https://sofinnovapartners.com/portfolio/innate-pharma-sa2024-04-02T06:31:54Z https://sofinnovapartners.com/portfolio/biosyntia2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/enginzyme2022-01-03T11:31:32Z https://sofinnovapartners.com/portfolio/pincell2025-07-07T14:35:14Z https://sofinnovapartners.com/portfolio/genespire2024-09-06T13:39:57Z https://sofinnovapartners.com/portfolio/maxcyte2023-09-05T13:04:47Z https://sofinnovapartners.com/portfolio/moon-surgical2023-06-23T09:16:47Z https://sofinnovapartners.com/portfolio/nitrase-therapeutics2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/enthera2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/myricx-pharma2026-07-06T05:15:33Z https://sofinnovapartners.com/portfolio/catamaran-bio2022-01-03T11:31:33Z https://sofinnovapartners.com/portfolio/redxpharma2023-10-03T10:29:04Z https://sofinnovapartners.com/portfolio/noema-pharma2022-01-03T11:31:33Z https://sofinnovapartners.com/news/page/22026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/32026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/42026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/52026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/62026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/72026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/82026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/92026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/102026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/112026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/122026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/132026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/142026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/152026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/162026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/172026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/182026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/192026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/202026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/212026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/222026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/232026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/242026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/252026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/262026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/272026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/282026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/292026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/302026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/312026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/322026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/332026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/342026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/352026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/362026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/372026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/382026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/392026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/402026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/412026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/422026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/432026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/442026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/452026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/462026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/472026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/482026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/492026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/502026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/512026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/522026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/532026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/542026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/552026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/562026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/572026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/582026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/592026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/602026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/612026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/622026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/632026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/642026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/652026-09-04T10:09:33Z https://sofinnovapartners.com/news/page/662026-09-04T10:09:33Z